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Summary 
 
During development growth and sexual differentiation are closely interrelated. In this context, 
the growth hormone (GH)/insulin-like growth factor (IGF)-I system and sex steroids are of 
critical importance. However, the potential interference of estrogen(s) and the GH/IGF-I 
system during development has not been investigated in fish. In order to study this potential 
interaction two different experimental approaches were chosen.  
 
1. A population of tilapia was fed during 10-40 day post fertilization (DPF) with 17α-
ethinylestradiol (EE2) enriched food. At 50, 75, 90 and 165 DPF, body length (BL), body 
weight (BW), sex ratio, serum IGF-I (radioimmunoassay) were measured. Pituitary GH 
mRNA, and IGF-I and estrogen receptor α (ERα) mRNA were quantitated in liver, brain, 
gonads and gills (real-time PCR) and the IGF-I mRNA results correlated to those of in situ 
hybridisation for IGF-I. 
EE2 treatment led to a shift in sex ratio towards more females (165 DPF: 47.2 ± 8.5% 
females in control to 86.5 ± 14.1% in EE2 fed) and to severe progressive decrease in BL and 
BW in both sexes. Both parameters were significantly lowered from 90 DPF onwards (90 
DPF - BL: -16.9% in males, -13.4% in females; BW: -47.4% in males, -32.3% in females; 
165 DPF - BL: -19.5% in males, -15.2% in females; BW: -46.2% in males, -40.1% in 
females). Thus, developmental exposure to EE2 had persistent effects on sex ratio and 
growth. 
At 75 DPF, in males the IGF-I serum level was significantly decreased in the EE2-
treated group (5.65 ± 1.18 ng/mL) when compared to the controls (9.70 ± 2.06 ng/mL) while 
in females there was only a trend to reduce IGF-I serum level. In correlation, liver IGF-I 
mRNA was reduced at 75 DPF and recovered later. In situ hybridisation revealed a reduced 
number of hepatocytes containing IGF-I mRNA after EE2 treatment in male and female liver. 
In parallel to the suppression of IGF-I mRNA, ERα was transiently highly induced in both 
sexes, e.g. at 75 DPF, ERα mRNA was raised to the 2.2-fold in males and the 37-fold in 
females. Thus, growth impairment by estrogen(s) in fish may be due to prolonged direct 
suppression of liver IGF-I synthesis and release.  
In female but not in male brain IGF-I mRNA was significantly suppressed at 75 DPF. 
In parallel, the number of neurones showing IGF-I mRNA was largely reduced in female 
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brain when compared to control. Brain ERα mRNA exhibited no significant changes at any 
experimental stage.  
Pituitary GH mRNA was significantly decreased after EE2 treatment: in males at 165 
DPF (2.33-fold) and in females at 75 DPF (2.27-fold) and at 90 DPF (3-fold). In parallel, ERα 
mRNA was significantly raised at 165 DPF (3.38-fold) in the male pituitary  and in the female 
pituitary at 75 DPF (2.55-fold)  and at 90 DPF (2.7-fold). 
 A transient downregulation of IGF-I mRNA occurred in ovaries (75 DPF) and testes 
(90 DPF). In agreement, in situ hybridisation revealed less IGF-I mRNA signals in granulosa 
and germ cells. In male gonad, a significant raise in ERα mRNA was found from 50 to 90 
DPF but in female gonad ERα mRNA was significantly increased at 50 DPF followed by a 
significant decrease at 75 DPF.  
In gills, IGF-I mRNA expression was significantly reduced only in males (50 DPF). In 
correspondence, the number of IGF-I mRNA containing chloride cells in the gill filament 
epithelium was reduced. ERα mRNA was significantly decreased in gills of both sexes only at 
50 DPF.  
In summary, the results of the EE2 feeding experiments show for the first time that 
developmental estrogen treatment impairs GH/IGF-I expression in fish, and that the effects 
persist. These long-lasting effects seem to be exerted both indirectly via inhibition of pituitary 
GH and directly by suppression of local IGF-I in organ-specific cells. 
 
2. Because our experiments with feeding of high doses of EE2 during development indicated 
that estrogen treatment impairs GH/IGF-I expression in fish and that these effects persist, we, 
consecutively, studied the effects of exposure to low doses of EE2 to developing tilapia. 
Female and male monosex populations were exposed to environmental concentrations 
(5 ng/L, 25 ng/L) of EE2 in the surrounding water (10-100 DPF). The actual EE2 
concentrations after 36 h of exposure were somewhat lower than the applied concentrations (5 
ng EE2/L aquaria: 4.34 ± 0.85 ng EE2/L; 25 ng EE2/L aquaria: 16.23 ± 5.74 ng EE2/L). The 
following parameters were determined at 30, 50, 75 and 100 DPF: sex ratio, BL, BW, and 
mRNA expression levels of IGF-I and ERα in liver, brain, gonads and gills (real-time PCR).  
Sex ratio had shifted at 75 and 100 DPF after exposure to both 5 and 25 ng EE2/L. 
Both female and male monosex fish populations exhibited a higher percentage of females.  
Growth was more pronouncedly reduced in male than in female fish. In males, from 
50 DPF on both BL and BW were significantly decreased in fish exposed in either 5 or 25 ng 
EE2/L. At 100 DPF, BL was reduced by about 9.5% (5 ng EE2/L) and 11% (25 ng EE2/L) 
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and BW by about 25% (5 and 25 EE2/L). In females, both parameters showed only a trend to 
decrease.  
In the liver of both sexes, IGF-I mRNA levels were significantly raised after exposure 
to both EE2 concentrations. This rise was accompanied by elevated ERα levels. At later 
stages (50–100 DPF), both IGF-I and ERα mRNA were decreased again. In general, the 
suppression of IGF-I expression was more pronounced in males than in females. 
A sex difference was observed between the responses of male and female brain to EE2 
exposure. In males, IGF-I mRNA was significantly suppressed only with 25 ng EE2/L (30, 50 
DPF). ERα mRNA was significantly elevated at 30 DPF at both EE2 concentrations and 
decreased at 100 DPF. In females, IGF-I mRNA was suppressed (50, 75 DPF) under both 
EE2 concentrations and later recovered, and ERα mRNA was suppressed over the whole 
treatment phase with several significant stages. 
A marked sex-specific difference was also found in the gonads. In testes, ERα was 
continuously, in part significantly, suppressed at 30 DPF (25 ng EE2/L) and at 50 and 100 
DPF (5 ng EE2/L). The suppressed ERα mRNA expression levels were paralleled by 
continuously decreased IGF-I mRNA levels. In ovary, no significant changes in ERα mRNA 
were detected. The IGF-I mRNA levels showed a tendency to increase with time and were 
significantly upregulated at 100 DPF with both EE2 concentrations. 
In gills, IGF-I mRNA expression was significantly declined only at 50 DPF (25 ng 
EE2/L) in both sexes. ERα mRNA was significantly increased  in males at 30 and 75 DPF (25 
ng EE2/L) while in females ERα mRNA was significantly decreased at 50 and 70 DPF.  
In summary, even low concentrations of EE2 as can be found in the environment are 
capable of a significant impairment of growth and differentiation of developing fish. This 
again underlines the importance of the interactions between the estrogen and the GH/IGF-I 
system. 
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Zusammenfassung 
 
Während der Entwicklung sind Wachstum und sexuelle Differenzierung eng 
miteinander verflochten. In diesem Zusammenhang sind Östrogen und das 
Wachstumshormon (GH)/Insulin-like growth factor (IGF)-I System von besonderer 
Bedeutung. Dennoch sind mögliche Interaktionen von Östrogen und dem GH/IGF-I System 
während der Entwicklung beim Fisch noch nicht untersucht worden. Um potentielle 
Interaktionen zu untersuchen, wurden zwei verschiedene experimentelle Ansätze gewählt. 
 
1. Eine Tilapiapopulation wurde vom 10. bis 40. Tag nach Befruchtung (DPF) mit 
17α-Ethinylestradiol (EE2)-angereicherter Nahrung gefüttert. An den Stadien 50, 75, 90 und 
165 DPF wurden Körperlänge (KL), Körpergewicht (KG), Geschlechterverteilung und der 
IGF-I Serumspiegel (mittels Radioimmunoassay) gemessen. Die GH-mRNA Expression in 
der Hypophyse sowie IGF-I-und Östrogenrezeptor α (ERα) mRNA-Expression wurden in 
Leber, Gehirn, Gonaden und Kiemen (mittels Real-time PCR) bestimmt und die Ergebnisse 
für IGF-I mit den Resultaten einer IGF-I In situ-Hybridisierung verglichen.  
Die Behandlung mit EE2 führte zu einer Verschiebung der Geschlechterverteilung 
zugunsten der Weibchen (165 DPF: 47.2 ± 8.5% Weibchen in der Kontrollgruppe gegenüber 
86.5 ± 14.1% bei den mit EE2 gefütterten Tieren) und zu schweren progressiven 
Beeinträchtigungen von KL und KG bei beiden Geschlechtern. Beide Parameter waren 
signifikant erniedrigt beginnend mit dem Stadium 90 DPF (90 DPF - KL: -16.9% bei 
Männchen, -13.4% bei Weibchen; KG: -47.4% bei Männchen, -32.3% bei Weibchen; 165 
DPF - KL: -19.5% bei Männchen, -15.2% bei Weibchen; KG: -46.2% bei Männchen, -40.1% 
bei Weibchen). Somit hatte die Exposition gegenüber EE2 während der Entwicklungsphase 
dauerhafte Veränderungen der Geschlechterverteilung und des Wachstums zur Folge. 
Am 75 DPF war bei den Männchen der IGF-I Serumspiegel signifikant vermindert in 
der EE2-behandelten Gruppe (5.65 ± 1.18 ng/L) im Vergleich zu den Kontrolltieren (9.7 ± 
2.06 ng/L) während bei den Weibchen lediglich ein Trend zu einem erniedrigten IGF-I 
Serumspiegel bestand. Dementsprechend war die IGF-I mRNA Expression in der Leber am 
75 DPF reduziert und erholte sich später. Die In situ-Hybridisierung zeigte in der männlichen 
und weiblichen Leber nach EE2-Behandlung eine verminderte Anzahl von Hepatozyten, die 
IGF-I mRNA enthielten. Parallel zur Erniedrigung der IGF-I Genexpression war die ERα 
Genexpression vorübergehend stark erhöht, beispielsweise am 75 DPF auf das 2.2fache bei 
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Männchen und das 37fache bei Weibchen. Somit könnte die Beeinträchtigung des Wachstums 
durch Östrogene beim Fisch auf einen verlängerten direkten supprimierenden Effekt auf die 
IGF-I Synthese und Freisetzung durch die Leber zurückzuführen sein. 
Im weiblichen, nicht aber im männlichen Gehirn, war die IGF-I Genexpression bei 
Stadium 75 DPF signifikant supprimiert. Dementsprechend war zu diesem Zeitpunkt die 
Anzahl von Neuronen, die IGF-I mRNA aufwiesen, beim weiblichen Gehirn deutlich 
reduziert im Vergleich zu den Kontrolltieren. Bei keinem Entwicklungsstadium zeigte die 
ERα Genexpression im Gehirn signifikante Veränderungen. 
Bei beiden Geschlechtern war die GH mRNA Expression in der Hypophyse nach EE2-
Behandlung signifikant erniedrigt bei den Männchen am 165 DPF (2.33fach) und bei den 
Weibchen am 75 DPF (2.27fach) und 90 DPF (3fach). Gleichzeitig war die ERα 
Genexpression signifikant erhöht, am 165 DPF (3.38fach) in der männlichen Hypophyse und 
am 75 DPF (2.55fach) und 90 DPF (2.7fach) in der weiblichen Hypophyse.  
Eine vorübergehende Erniedrigung der IGF-I mRNA Expression erfolgte in den 
Ovarien (75 DPF) und Hoden (90 DPF). In Übereinstimmung damit zeigte auch die In situ-
Hybridisierung weniger IGF-I mRNA Signale in den Granulosa- und Keimzellen. In der 
männlichen Gonade wurde ein signifikanter Anstieg der ERα mRNA in den Stadien 50-90 
DPF gefunden, während in der weiblichen Gonade die ERα mRNA signifikant erhöht war am 
50 DPF, aber gefolgt von einem signifikanten Abfall am 75 DPF.  
In den Kiemen wurden signifikante Veränderungen der IGF-I mRNA Expression nur 
bei den Männchen (50 DPF) erzielt. Dementsprechend war die Anzahl der IGF-I mRNA-
enthaltenden Chloridzellen im Kiemenepithel vermindert. Nur am 50 DPF war bei beiden 
Geschlechtern die ERα mRNA signifikant erniedrigt. 
Zusammenfassend kann festgehalten werden, dass die Ergebnisse der Experimente mit 
Fütterung von EE2 zum ersten Mal zeigen, dass die Behandlung mit Östrogen während der 
Entwicklung die GH/IGF-I Expression beim Fisch beeinträchtigt, und dass diese Effekte 
fortbestehen. Die nachhaltigen Effekte scheinen sowohl indirekt über die Erniedrigung von 
Wachstumshormon in der Hypophyse als auch direkt über die Unterdrückung des lokalen 
IGF-I in den organ-spezifischen Zellen zu wirken. 
 
2. Da unsere Fütterungs-Experimente mit hochdosiertem EE2 darauf hindeuteten, dass 
Östrogen-Behandlung während der Entwicklung die GH/IGF-I Expression beim Fisch 
beeinträchtigt, und dass diese Wirkungen fortbestehen, haben wir daraufhin die 
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Auswirkungen einer Exposition gegenüber niedrigen EE2-Dosen auf Tilapien während der 
Entwicklung untersucht. 
Weibliche und männliche Monosex-Populationen von Tilapien wurden 
Umweltkonzentrationen (5 ng/L, 25 ng/L) von EE2 während 10-100 DPF ausgesetzt. 
Messungen der aktuellen EE2-Konzentrationen nach 36 Stunden Exposition ergaben, dass 
diese niedriger als die applizierten Dosen waren (5 ng EE2/L Aquarien: 4.34 ± 0.85 ng 
EE2/L, 25 ng EE2/L Aquarien: 16.23 ± 5.74 ng EE2/L). Folgende Parameter wurden zu den 
Stadien 30, 50, 75 und 100 DPF bestimmt: Geschlechterverteilung, KL, KG, und die 
Genexpressionsveränderungen von IGF-I und ERα mRNA in Leber, Gehirn, Gonaden und 
Kiemen (Real-time PCR). 
Die Geschlechterverteilung war verschoben (75 und 100 DPF). Sowohl die weibliche 
als auch die männliche Monosex-Population zeigten einen höheren Anteil an Weibchen nach 
Exposition gegenüber 5 und 25 ng EE2/L. Das Wachstum war bei den Männchen stärker 
reduziert als bei den Weibchen. Bei den Männchen waren KL und KG vom Stadium 50 DPF 
an bei den Fischen, die gegenüber 5 und 25 ng EE2/L exponiert waren, signifikant reduziert. 
Am Ende des Experimentes (100 DPF) war die KL um ca. 9.5% (5 ng EE2/L) bzw. 11% (25 
ng EE2/L) vermindert und das KG um ca. 25% (5 und 25 ng EE2/L). Bei den Weibchen 
zeigten beide Parameter lediglich eine tendenzielle Reduktion. 
Bei beiden Geschlechtern war die Expression von IGF-I mRNA in der Leber nach 
Exposition gegenüber beiden EE2-Konzentrationen signifikant erhöht. Dieser Anstieg war 
von einer erhöhten ERα Genexpression begleitet. In den späteren Untersuchungsstadien (50-
100 DPF) waren sowohl IGF-I- als auch ERα Genexpression wieder erniedrigt. Im 
Allgemeinen war die Unterdrückung der IGF-I Genexpression bei den Männchen stärker 
ausgeprägt als bei den Weibchen. 
Die Reaktionen des männlichen und weiblichen Gehirns gegenüber der EE2-
Behandlung zeigten deutliche Unterschiede. Bei den Männchen war die IGF-I mRNA 
Expression nur bei 25 ng EE2/L (30 und 50 DPF) signifikant erniedrigt. Die ERα mRNA war 
signifikant erhöht bei EE2 Exposition (30 DPF) und später erniedrigt (100 DPF). Bei den 
Weibchen war die IGF-I Genexpression bei beiden EE2-Konzentrationen supprimiert (50 und 
75 DPF) und kehrte später zu den Ausgangswerten zurück. Bei beiden EE2-Konzentrationen 
zeigte die ERα Genexpression eine – mitunter signifikante – Absenkung während der 
gesamten Behandlungsdauer.  
Eine bemerkenswerte geschlechtsspezifische Reaktion wurde auch in den Gonaden 
festgestellt. Im Hoden war die ERα Genexpression kontinuierlich, teilweise signifikant, 
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erniedrigt, nämlich an den Stadien 30 DPF (25 ng EE2/L) sowie 50 und 100 DPF (5 ng 
EE2/L). Die supprimierten ERα Genexpressionswerte waren dauerhaft begleitet von einer 
erniedrigten IGF-I Genexpression. Im Ovar wurde keine signifikante Veränderung der ERα 
Genexpression gemessen. Die IGF-I Genexpressionswerte zeigten einen tendenziellen 
Anstieg mit Fortdauer der Exposition und waren bei beiden EE2-Konzentrationen am 100 
DPF signifikant erhöht. 
In den Kiemen wurde ein signifikanter Abfall der IGF-I mRNA Expression nur am 50 
DPF (25 ng/L) bei beiden Geschlechtern gefunden. Die ERα Genexpression war bei den 
Männchen an den Stadien 30 und 75 DPF (25 ng/L) signifikant erhöht, während sie bei den 
Weibchen an den Stadien 50 und 75 DPF signifikant erniedrigt war. 
Zusammenfassend kann festgestellt werden, dass sogar niedrige Konzentrationen von 
EE2, wie sie in der Umwelt gemessen werden, in der Lage sind, Wachstum und 
Differenzierung von Fischen während der Entwicklung signifikant zu beinträchtigen. Dies 
unterstreicht die Bedeutung der Interaktionen des Östrogen- und des GH/IGF-I-Systems. 
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1. Introduction 
 
1.1. The endocrine disruption hypothesis 
 
The endocrine disruption hypothesis claims that synthetic as well as naturally occurring 
chemical substances in the environment can disrupt the normal functions of the endocrine 
system and its hormones in humans and wildlife. Krimsky S., in his book “Hormonal Chaos” 
(2000), claims that “from the standpoint of human pathology, the environmental endocrine 
hypothesis could turn out to be the most significant environmental health hypothesis since the 
discovery of chemical mutagenesis.” During the last 20 years this hypothesis has received 
increasing scientific and public attention (Colborn and Clement, 1992; McLachlan, 2001; 
Matthiessen, 2003). A number of adverse alterations observed in wildlife, e.g. the disturbed 
sexual development in birds (Fry and Toone, 1981) or the occurrence of intersex in wild fish 
(Jobling et al., 1998), have been thought to be caused by exposure to endocrine-disrupting 
chemicals (EDCs). Over the past decade scientists have reported high levels of deformities 
and defects in fish eggs and larvae from the North sea (Dethlefsen et al., 1996), increased 
incidents of idiopathic hepatic lesions in English sole (Parophrys vetulus) from urban areas in 
the United States (Myers et al., 1991) and “feminisation” of male fish near sewage treatment 
outlets in rivers and estuaries (Sumpter and Jobling, 1995).  
The seriousness of the problem has led the Organisation for Economic Cooperation 
and Development (OECD) and the European Union to initiate extended research programs 
towards new guidelines and regulations on EDCs. An EDC is defined by the World Health 
Organisation (2002) as “an exogenous substance or mixture that alter function(s) of the 
endocrine system and consequently produces adverse health effects in an intact organism, or 
its progeny, or (sub)populations”.  
 
1.2. Estrogenic acting compounds found in the environment 
 
Organisms have evolved sensitivity to endogenous and exogenous chemicals in order to 
respond to physical or biological stimuli in the environment and to maintain internal 
homeostasis, however, this sensitivity at the same time makes organisms vulnerable to 
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inadvertent signals in their environment (Cheek et al., 1998). Through their effects on 
metabolism, distribution or function of endogenous hormones, EDCs have the potential to 
disrupt hormone-controlled physiological processes such as development, growth, stress 
responses, sexual differentiation or reproduction. A variety of environmental substances has 
been shown to interfere with the endocrine system of exposed organisms either by mimicking 
hormone action or by disturbing hormone synthesis and metabolism (Segner et al., 2006).     
Examples of environmental EDCs include natural estrogens (e.g. from human 
excretion), synthetic estrogens (e.g. from contraceptives), phytoestrogens (e.g. from soy or 
wood-processing), mycoestrogens, chlorinated pesticides, such as 
dichlorodiphenyltrichloroethane (DDT), polychlorinated biphenyls (PCBs), polybrominated 
flame retardants and other industrial chemicals such as alkylphenols or phtalates, plastics, 
detergents, drugs, cosmetics, herbicides, and others, entering the environment through 
industrial and sewage discharges, active application and runoff. A lot of “inadvertent” 
estrogens are much less potent than the steroidal estrogen, 17β-estradiol (E2) (McLachlan, 
2001). Like all steroid hormones, E2 contains the three-ring phenanthrene; whereby for 
estrogenicity, the first or A ring must contain a phenolic hydroxyl group (Fig. 1). 
 
 
Fig. 1 Chemicals found in the environment reported to be estrogenic (McLachlan, 2001). 
 
In 1938, diethylstilbestrol (DES) was discovered by Sir Charles Dodds and colleagues 
(Dodds et al., 1938). It was orally active, relatively stable, and less expensive to produce than 
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isolated or synthesized steroidal estrogens. DES quickly became the synthetic estrogen of 
choice for medicine and, later, agriculture. Its medical uses included estrogen replacement 
therapies, lactation suppression, postcoital contraception, pregnancy maintenance, and 
prostate cancer therapy. In agriculture, DES was mainly used to chemically caponize chicken 
and stimulate growth in cattle. The widespread use of DES in cattle feed lots led to the 
introduction of tons of potent estrogens into the ecosystem. Its use was discontinued in 1971 
after a report that associated in utero DES exposure with vaginal clear cell adenocarcinoma, 
in a small number (~0.1%) of daughters of women who had taken the drug during pregnancy 
(Herbst et al., 1971). Subsequent studies in women exposed to DES have detected 
nonneoplastic abnormalities such as anatomical malformations of the cervix, vagina, and 
uterus as well as decreased fertility and less successful pregnancies (Mittendorf, 1995; Herbst, 
2000). Experiments with male and female ERα knockout mice have indicated that DES elicits 
its effects through an ERα-dependent signalling pathway (Henley and Korach, 2006). 
Very recently, a synthetic estrogenic component of commonly used oral 
contraceptives, 17α-ethinylestradiol (EE2), was found in waste water effluent in Europe 
(Kalbfus, 1995; Harries et al., 1997; Desbrow et al., 1998; Larsson et al., 1999; Baronti et al., 
2000; Lagana et al., 2000). EE2 is even more potent than the naturally occurring E2. Purdom 
et al. (Purdom et al., 1994) have reported that EE2 at a concentration of as low as 0.1 ng/L 
affects the reproductive function of male rainbow trout and at a concentration of 10 ng/L 
induced the synthesis of vitellogenin (VTG) in immature cyprinids. Lange and colleagues 
(Lange et al., 2001) have demonstrated that the no-observed-effect concentrations (NOEC) for 
growth, survival, and reproduction (as eggs production) for the F0 adult phase and F1 larval 
survival were ≥1.0 ng EE2/L. In a recent study in Canada authors were unable to detect any 
EE2 in the wastewater treatment plants (WWTP) samples by YES bioassay and E-Screen 
bioassay (Nelson et al., 2007). However, concentrations of EE2 effluents in Germany had 
been found in the range of 0.3-0.5 ng/L (Kalbfus, 1995). In the UK, EE2 concentrations in 
effluents were up to 7 ng/L (Desbrow et al., 1998), while Larsson et al. (Larsson et al., 1999) 
reported Swedish sewage treatment works effluent to contain EE2 at up to 4.5 ng/L in contrast 
to the traces amounts reported by Lagana et. al. (2000) for Italy. Baronti et al. (2001) have 
shown that mean EE2 concentrations in Roman WWTP influent and effluent were 3 ng/L and 
0.4 ng/L, respectively. Layton et al. (2000) also have reported that as much as 80% of the EE2 
may be bound to the sewage sludge and thus be removed from the aqueous phase.  
The most commonly studied phytochemicals are the flavonoids, including isoflavones 
and flavones, represented by Genistein and Luteolin, respectively. It has been shown that 
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isoflavones, like Genistein, bind to vertebrate forms of ERα or ERβ and alter the transcription 
of estrogen-responsive genes (Kuiper et al., 1998). Genistein also has potent tyrosine kinase-
inhibiting effects (Zava and Duwe, 1997). Also Zearalenone, a fungal mycotoxin produced by 
Fusarium, binds to the ER (Powell-Jones et al., 1981), was uterotropic in the newborn rat 
(Sheehan et al., 1984), impaired fertility in cattle (Roine et al., 1971), and induced 
hyperestrogenicity in swine (Bristol and Djurickovic, 1971). Studies on sheep exposed to the 
phyto-estrogen Coumestrol displayed macroscopic changes within the genital tract, of which 
the uterine alterations were especially prominent (Cantero et al., 1996). Resveratrol is a 
phytoestrogen that has the ability to bind to ERs and evoke biological effects like estrous 
cycle irregularity, ovarian hypertrophy, and alterations in sociosexual behavior (Henry and 
Witt, 2006).  
The best known example for “inadvertent” chemicals is the pesticide 
Dichlorodiphenyltrichloroethane (DDT). In 1950 Burlington and Lindeman (Burlington and 
Lindeman, 1950) showed that DDT can estrogenize cockerels. Later Conney and colleagues 
(Conney et al., 1967) rediscovered it while testing various pesticides as inducers of 
cytochrome P450 enzyme activity.  
In addition to DDT, other chlorinated hydrocarbons, PCBs, have been shown to 
function estrogenic both by in vivo and in vitro assays (Korach et al., 1988).  
Nonylphenol (NP) is an industrial chemical found in a variety of commercial products. 
It belongs to a group of synthetic compounds that mimic the effect of estrogens by binding to 
the ER (Flouriot et al., 1995). NP induces VTG synthesis in various fish species (Sumpter and 
Jobling, 1993; Madsen et al., 1997; Christiansen et al., 1998). Soto et al. (1991) showed that 
some plastic petri dishes and tubes contained a residue of p-nonylphenol. Thus, this 
alkylphenol contaminant has been shown to be estrogenic, supporting the association between 
p-nonylphenol contamination and feminisation of fish in UK streams (Sumpter and Jobling, 
1993). 
Bisphenol-A (BPA) was found to be an efficient cross-linking chemical and came to 
be widely used in the production of plastic polymers, primarily polycarbonates. In 1993, the 
BPA production in the USA amounted to 640,000,000 kg; of that, 44,000 kg (<0.10%) were 
recycled, land filled, incinerated, or released into the environment (McLachlan et al., 2001). 
Levels of phenolic xenoestrogens in river water can be surprisingly high. Measured 
concentrations of BPA, 4-tert-octylphenol and the technical isomer mixture of 4-nonylphenol 
in the river water samples from Germany  ranged from 20 to 1927 ng/L, <10 to 770 ng/L and 
<10 to 420 ng/l, respectively (Quednow et al., 2007). Similar analyses from Turkish rivers 
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found that alkylphenols were not present in the water but concentrated in the sediments (1–
4.46 μg/g) (Uguz et al., 2003). Higher values have been reported from England (15 μg/g) and 
the USA (70 μg/g) (Blackburn et al., 1999). As would be expected for these lipophilic 
compounds, analysis revealed that alkylphenols contaminate the tissues of fish. Values of 
0.1–0.8 μg/g NP have been estimated for fish sampled from both English and Turkish rivers 
(Blackburn et al., 1999; Uguz et al., 2003).  
At least in summer months, fish may also be contaminated with camphor derivatives 
from sun-screen creams used by people swimming in lakes and rivers (Poiger et al., 2004). 
The levels in fat tissue in fish from the Meerfelder Maar (Germany) were similar to the 
concentration of 7 mg/kg, which has been reported to affect development and reproduction in 
medaka (Inui et al., 2003).  
Phthalate esters are used extensively as plasticizers and stabilizers in a variety of 
plastics and consumer goods. Exposure to phthalates through ingestion, inhalation, and 
dermal absorption occurs throughout life (Latini, 2005). Phthalate esters, including di(n-butyl) 
phthalate (DBP) (Fig. 2), adversely affect the male rat reproductive tract both after prenatal or 
postnatal exposure. The effects include disrupted epididymal development, hypospadia, 
cryptorchism, and reduced fertility. Furthermore, neither DBP nor its major metabolite, 
monobutyl phthalate, physically interact with the androgen receptor (AR), indicating that the 
antiandrogenic effects of DBP occur through AR-independent mechanisms (Foster et al., 
2001). 
 
Fig. 2 The chemical structures of selected EDCs. 
 
In general, in EDCs, there is often, but not always, the presence of an aromatic ring or 
two. Several representative chemicals contain chlorine atoms. The role that chlorine plays in 
hormonal activity is still not clear. For instance Kepone (Fig. 1), a structurally restricted, 
cubic molecule containing chlorine on every carbon but one, is known to be estrogenic 
(Eroschenko and Palmitter, 1980).  
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Methoxyacetic acid (MAA) (Fig. 2) is the major metabolite of ethylene glycol 
monomethyl ether (EGME), an industrial solvent commonly used in varnishes, paints, dyes, 
and fuel additives (Johanson, 2000). Occupational exposure to both EGME and MAA has 
been associated with subfertility, spontaneous abortion, and reduced sperm counts (Welch et 
al., 1988; Ratcliffe et al., 1989; Correa et al., 1996). MAA exerts its effects by potentiating the 
ligand-induced transcriptional activity of ERα, ERβ, progesterone receptor (PR), AR, and the 
thyroid hormone receptor (TRβ). By this potentiation even weak nuclear receptor agonists 
found in the environment are able to produce responses of full agonists (Henley and Korach, 
2006). 
As yet, no synthetic environmental chemicals have been reported that function as 
androgens, but twenty years ago, Howell and colleagues (1980) described masculinization of 
female mosquito fish, Gambusia affinis holbrooki, which were caught downstream from the 
effluent discharged from a paper mill in Cantonment, Florida. Mycobacterium smegmatis, 
which produces androgens as metabolic products, had formed extensive colonies in the 
effluent path and was utilizing the plant cholesterol (stigmasterol) as carbon sources and 
metabolizing the plant sterol to a potent androgen, androstenedione.  
A growing number of pesticides have been recently recognized as androgen 
antagonists. The organophosphate insecticide, Fenitrothion, has also been shown to be a 
competitive reversible inhibitor of the AR (Tamura et al., 2001). The herbicide Linuron has 
turned out to be a competitive binding ligand for the AR in rats or humans, and altered 
androgen-dependent gene expression in castrate rats (Lambright et al., 2000). Gray et al. 
(1999) demonstrated that Vinclozolin produces subtle alterations in the differentiation of the 
external genitalia, ventral prostate, and nipple tissue in male rat offspring. Vinclozolin is 
metabolized to at least two active forms, that display antiandrogenic activity by binding to the 
AR.  
 
1.3. Genomic and non-genomic mechanisms of ED action 
 
The biological actions of hormones, such as estrogens, progesterone, androgens, and 
thyroxine, are mediated via high affinity protein receptors within the target cells. Steroids, 
such as the estrogens, normally circulate as their sulphated derivatives which have no 
hormonal effects; the free steroid is released at the target tissue by the action of tissue-bound 
sulphatase enzymes. Other steroids circulate in the blood stream bound to carrier proteins or 
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serum albumin. All steroids are fat-soluble and readily cross the cell membrane, interacting 
with dimeric receptor proteins; in the case of estrogens these are ER-α and ER-β, although 
recent evidence has been provided for a third class, ER-γ, in fish and, possibly, mammals 
(Dodge et al., 1996; McLachlan et al., 2001). The affinity of a steroid for its receptor is high. 
The steroid-receptor complex binds to target regions of DNA termed “response elements”. 
This activates a cascade of reactions. Classically, EDCs have been thought to exert their 
effects exclusively by genomic mechanisms, acting as steroid agonists or antagonists by 
binding to the receptor. However, there is evidence that some estrogenic compounds do not 
act via the ER and thus non-genomic effects may also play a role in the mechanisms of action 
of EDCs (Fig. 3). 
 
 
Fig. 3 The multiple mechanisms of estradiol (E2) and estrogen receptor (ER) signalling. The biological 
effects of E2 are mediated through at least four ER pathways. 1, classical ligand-dependent, E2-ER complexes 
bind to EREs in target promoters leading to an up- or downregulation of gene transcription and subsequent tissue 
responses. 2, ligand-independent. Growth factors (GF) or cyclic adenosine monophosphate (not shown) activate 
intracellular kinase pathways, leading to phosphorylation (P) and activation of ER at ERE-containing promoters 
in a ligand-independent manner. 3, ERE-independent, E2-ER complexes alter transcription of genes containing 
alternative response elements such as activator protein 1 (AP-1) through association with other DNA-bound 
transcription factors (Fos/Jun), which tether the activated ER to DNA, resulting in an up-regulation of gene 
expression. 4, Cell-surface (nongenomic) signaling, E2 activates a putative membraneassociated binding site, 
possibly a form of ER linked to intracellular signal transduction pathways that generate rapid tissue responses. 
(Hall et al., 2001).  
 
Classical genomic effects (ligand-dependent, ligand-independent and ERE-
independent) have been demonstrated for natural compounds (e.g. coumestrol), 
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pharmaceuticals (e.g. tamoxifen and DES) and industrial chemicals (e.g. octylphenol and 
BPA). These compounds bind to the ER and thus act as pseudoestrogens, resulting in 
feminising effects ( Laws et al., 1995; Gray and Metcalfe, 1999; Stroheker et al., 2004). 
Goksøyr A. (2006) divided the mechanisms of action of EDCs into: (1) 
agonist/antagonistic effect (“hormone mimics”), (2) disruption of production, transport, 
metabolism or secretion of natural hormones, and (3) disruption of production and/or function 
of hormone receptors (Goksøyr et al., 2003). Results from his laboratory indicate that one 
single compound can utilize all of these mechanisms, apparently depending on the doses 
given to the organism. Studies with Atlantic salmon (Salmo salar), have shown that 4-
nonylphenol can act as estrogen mimic (Arukwe et al., 1997a), steroid metabolism disruptor 
(Arukwe et al., 1997b), and by modulating ER levels (Yadetie et al., 1999). 
EDCs may also exert non-genomic effects by altering synthesis or availability of 
endogenous hormones. Steroids are initially formed from cholesterol via a series of reactions, 
which can involve cytochrome P450 (CYP) isoforms. CYP 2C11, 2A1, 2B1, 3A1 and 2C19 
catalyse critical stages; CYP 2C19 is the enzyme ‘aromatase’ which controls the formation of 
estrogens from precursors. Expression of CYPs from the 2B and 2C families occurs during 
the earliest stages of fetal development (You, 2004). Since they can be induced by 
environmental contaminants such as DDT and its analogues, this gives another mechanism by 
which EDC activity can occur. Compounds of the azole type, such as ketoconazole and the 
fungicide fenarimol, inhibit these CYP isoforms and consequently can also affect steroid 
synthesis (Hirsch et al., 1987). The now-banned anti-fouling agent tributyltin and its 
metabolites, are also thought to act by inhibition of aromatase (Alzieu, 2000). 
Estrogens and their steroid precursors are normally transported in the bloodstream as 
sulphonate esters. The esters are synthesised, using the cofactor 3′-phosphoadenosine-5′-
phosphosulphate, by cytosolic sulphotransferase enzymes with the isoforms SULT 1E1 and 
SULT 2A1. Sulphatases located on the surfaces of the target cells release the free steroids, 
which then can enter the cell. Any excess steroids are reconjugated and excreted from the 
cells. The importance of this pathway has been shown by inserting the gene for SULT 1E1 
into the MCF-7 breast cancer cell line resulting in a decrease of the proliferative response of 
the cells towards E2 (Falany et al., 2002). Hence, compounds which alter the 
sulphotransferase/sulphatase activity ratio can potentially affect the availability of endogenous 
estrogens to target tissues (Kirk et al., 2001). Many phenolic compounds, such as the 
alkylphenol plasticisers, inhibit both SULT 1E1 and SULT 2A1, and also act as substrates for 
SULT 1A1. Although this isoform mainly sulphonates phenols, it accepts estrogens as 
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substrates at relatively high concentrations and sulphonates alkylphenols at sub-micromolar 
levels (Harris et al., 2005). However, alkylphenols can cause significant inhibition of 
sulphotransferase activity at sub-micromolar concentrations, but some naturally occurring 
compounds, e.g. some types of flavonoids, are pronouncedly more potent (Kirk et al., 2001). 
 
1.4. Estrogen receptors in fish 
 
ERs are ligand-dependent transcription factors that regulate the expression of their target 
genes either directly, by binding to a specific cis-element called the estrogen-responsive 
element (ERE) in the promoters of target genes, or indirectly, via interactions with other 
transcription factors such as Sp1 or the AP1 complex (Hall et al., 2001). The ERs are divided 
into six functional domains designated A to F (Krust et al., 1986). The C domain (DNA 
binding-domain; DBD), and the E domain (ligand binding-domain; LBD), responsible for 
ligand binding, nuclear localization, and transcriptional activation (AF-2), are highly 
conserved with homologies of 90% and 100% respectively, between chicken, rat and man 
(Pakdel et al., 1989). In contrast, considerable divergence occurs in the N-terminal A/B 
domain, which contains a second activation function, AF-1, the D domain (hinge region), 
necessary for the maintenance of the three-dimensional structure of the ER (Zilliacus et al., 
1995; Hu and Lazar, 1999), and the C-terminal F domain.  
Recently, three estrogen receptors, ERα, ERβ and ERγ, have been identified in teleosts 
(Todo et al., 1996; Tchoudakova et al., 1999; Hawkins et al., 2000; Socorro et al., 2000, Kim 
et al., 2002). However, the biological significance of the multiple ERs still has to be fully 
elucidated. ERγ is closely related to ERβ, suggesting that it reflects a duplification of this 
gene. In zebrafish (Danio rerio), the ERα subtype is  now designated ER1, the ERβ1 subtype 
ER2b, and the ERβ2 subtype ER2a (Official Zebrafish Nomenclature Guidelines; 
http://zfin.org). Distinct patterns of expression for ER1 and ER2 have been documented in 
fish, but these patterns appear to vary between species. In Atlantic croaker (Micropogonias 
undulates), goldfish (Carassius auratus), seabream (Sparus aurata) and zebrafish, ER1 and 
ER2 exhibit broad tissue expression but, for the most part, are concentrated in liver and 
gonad, with considerably lower levels of expression in brain, pituitary, intestine, and muscle 
(Tchoudakova et al., 1999; Hawkins et al., 2000; Socorro et al., 2000; Menuet et al., 2002). In 
contrast to these findings, however, ER1 in African cat-fish (Clarias gariepinus) and ER2a in 
goldfish have been reported to be expressed predominantly in pituitary and brain, with 
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considerably lower levels of expression in gonads and liver (Ma et al., 2000; Choi and Habibi, 
2003; Teves et al., 2003). In fathead minnow (Pimephales promelas), ERs have been found to 
be expressed in brain, pituitary, liver, gonads, intestine, and gill of male and female fish, and 
ER2b and ER2a also in muscle. ER1 and ER2b were expressed predominantly in the liver, 
whereas ER2a was mainly expressed in intestine and lowest in liver. This differential 
expression is supported by the recent finding that fathead minnow exposed to 100 ng E2/L 
showed a significant 5-fold induction of ER1 in male liver but no effect was found on ER2b 
or ER2a expression (Filby and Tyler, 2005).  
 
1.5. Effects of EDCs 
 
1.5.1. In mammals 
 
Studies in mammals have shown that reproductive function can be affected by compounds of 
both natural and industrial origin. Phytoestrogens from clover have long been recognised as 
the cause of reproductive dysfunction and infertility in sheep and the compounds responsible 
have been identified as equol and coumestrol (Rossiter and Beck, 1966). Industrial chemicals 
can also act as EDCs in mammals. Phthalate esters such as diethylhexylphthalate (DEHP) are 
major components in polyvinyl chloride (PVC) plastics, which are frequently used in medical 
tubing and blood storage bags. DEHP is readily released from medical devices, and DEHP 
and its metabolites have been detected in urine from babies after intravenous infusions in a 
neonatal intensive care unit (Calafat et al., 2004). DEHP is an endocrine disrupter in rats, 
producing Leydig cell hyperplasia and also affecting systemic physiology (Akingbemi et al., 
2004). The main metabolite of DEHP, monoethylhexylphthalate (MEHP) acts in rats as an 
anti-estrogen at low doses but has estrogenic effects at higher levels (Shono and Suita, 2003). 
Di-n-butylphthalate (DBP) similarly reduced fertility in rabbits, whereby the effects became 
particularly apparent in the intrauterine period (Higuchi et al., 2003). Other plasticisers, such 
as nonyl- and octylphenols and their derivatives, also bind to the ERs. BPA also acts at the 
ERs in reproductive tissues and in high doses causes reproductive toxicity in rats and mice 
(Tan et al., 2003). Some UV filters in sunscreen creams are also estrogenic: 4-
methylbenzylidene camphor and 3-methylbenzylidene camphor are ligands for both ER 
subtypes, particularly ERα, and have shown to cause estrogenic effects in rats (Schlumpf et 
al., 2004; Durrer et al., 2005). 
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Also for human, exposure to EDCs has been discussed as possible cause of changes in 
sperm quality and quantity (Sharpe and Skakkebaek, 1993) or as cause of increases in the 
number of some types of breast, prostate and testicular cancer (Colborn et al., 1993; Safe and 
Zacharewski, 1997). Also increases in the prevalence of cryptorchism and hypospadia have 
been reported (Dolk et al., 2004). 
 
1.5.2. In birds, reptiles and amphibians 
 
Unlike mammals, sexual differentiation in birds depends on estrogen levels which regulate the 
development of the female phenotype. Feminised male birds with ovotestis and reduced male 
copulatory behaviour have been induced by EDCs such as DDT which are agonists at the ER 
(Fry and Toone, 1981).In the 1960s the use of DDT coincided with a decrease in reproductive 
ability of birds, particularly those at the top of the food chain. Egg-laying and calcification of 
the egg shell in birds depends on estrogen and Vitamin D. For example, the presence of 
organochlorines not only resulted in feminisation of male Japanese quail but also led to shells 
which were too fragile to hatch successfully or so thick that the chicks could not get out 
(Halldin et al., 2003). 
EDC effects have also been documented in alligators in Florida, where exposure to 
DDT and its metabolite DDE markedly decreased the egg hatching rate and increased juvenile 
mortality (Vonier et al., 1996). The surviving animals showed raised estradiol levels in both 
sexes. DDT and other organochlorines are now banned over most of the world. 
The commercially important weed killer atrazine has been known to exert estrogenic 
effects on tadpoles and adult frogs, to convert adult males into hermaphrodites and to retard 
gonadal development (Hayes et al., 2003). Furthermore, the exposure to exogenous steroids or 
steroid mimicking chemicals led to feminisation or masculinisation of Xenopus laevis 
tadpoles (Bogi et al., 2002; Kloas, 2002; Kloas and Lutz, 2006). 
 
1.5.3. In bony fish 
 
Endocrine disruption in fish by environmental estrogens and xenoestrogens is considered to 
be a major problem in fish populations (Jobling and Tyler, 2003a; Mills and Chichester, 
2005). For example, some of the pioneering work of Sumpter and coworkers in the United 
Kingdom showed the presence of feminized male fish in rivers downstream of waste water 
treatment plants. The occurrence has been associated with estrogens and some types of 
industrial chemicals in the water such as alkylphenols (Purdom et al., 1994; Desbrow et al., 
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1998; Routledge et al., 1998). Discharges from pulp and paper mill effluents also have been 
linked to alterations in endocrine function in fish, suggesting that plant byproducts can affect 
processes controlled by estrogens and androgens (Van der Kraak, 1998; Larsson et al., 1999; 
Park et al., 2001). Other examples of possible impairing effects of EDCs on fish populations 
have been related to tetrachlorodibenzodioxin and PCB in the Great Lakes, and polycyclic 
aromatic hydrocarbons at marine sites (Fairbrother et al., 1999). Recent research has 
demonstrated that many aquatic ecosystems receive inputs of estrogens, such as E2 and 
synthetic estrogens (Cargouet et al., 2004; Kolodziej et al., 2004). 
The aquatic environment is a sink for chemical substances, and therefore, aquatic 
animals are particularly endangered by the action of EDCs (Tyler et al., 1998). For teleost 
fish, observations such as the appearance of VTG, an egg yolk precursor that is produced by 
oviparous female fish in response to circulating plasma estrogens, in male fish (Purdom et al., 
1994; Allen et al., 1999) or gonadal and hormonal alterations (Jobling et al., 1998; 
Munkittrick et al., 1998; Bortone and Cody, 1999) have attracted attention to the 
contamination of the aquatic environment by EDCs and their potential impairing impact on 
wild fish populations (Jobling and Tyler, 2003). The original work conducted on freshwater 
fish in the UK established that treated sewage effluents were estrogenic and induced VTG in 
male individuals (Purdom et al., 1994).  
The estrogen-active substances contained in the effluents include natural and synthetic 
hormones but also synthetic substances such as alkylphenols (Desbrow et al., 1998). In 
addition to the production of VTG, exposure to treated sewage effluents has been thought to 
cause pathological alterations of gonad morphology, such as formation of intersex gonads, 
because feminisation of reproductive ducts or oocytes in predominantly testicular tissue 
appeared. Intersex as a consequence of exposure to estrogenic effluents has been most 
intensively studied in the roach, Rutilus rutilus (Jobling et al., 1998), and evidence has been 
presented that the reproductive capacity of intersex roach is reduced (Jobling et al., 2002). 
Any lipophilic contaminants in the water are readily absorbed. Because the 
detoxication capabilities of fish are less effective than those of mammals, the effects of EDCs 
are more apparent. Bioaccumulation also occurs, especially in bottom-feeding fish and those 
at the top of the food chain, because most EDCs are lipid-soluble and concentrated in fat 
tissues. Most studies available have been carried out on estrogen exposure, using the presence 
of VTG in the plasma of male fish as a biomarker for feminisation. A variety of effects of 
EDCs on fish populations have been reported. The domestic waste water effluent from 
sewage treatment works has been shown to be estrogenic, to cause hermaphroditism and 
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increase in plasma VTG in male fathead minnow (Hemming et al., 2001). This possibly 
reflects the presence of steroidal contraceptive agents such as EE2, which are not easily 
removed by conventional sewage treatments (D’Ascenzo et al., 2003; Cargouet et al., 2004). 
Similar effects have been reported for a wide range of fish species. In general, the 
experiments show that fish reproduction is very sensitive to environmental contamination, 
especially from sewage plants and industrial discharges (Arukwe, 2001). 
Plasticisers are examples of environmental compounds, which affect fish reproduction. 
Alkylphenols such as nonyl- and octylphenol are weak estrogen mimics, and exposure of fish 
to these compounds has been linked with increased mortality rates, reduced reproductive 
capacity and VTG synthesis in male fish and yolk degeneration in oocytes (White et al., 
1994). While the primary event of the estrogenic action of these compounds appears to be 
their binding to the ER, the mechanisms through which they disrupt physiological functions 
are not understood to date. 
Fish are appropriate models for testing EDCs, not only from the perspective of 
existing ecological impacts, but also in terms of species extrapolation. Particulary, there is a 
significant degree of conservation of basic aspects of the hypothalamic-pituitary-gonadal axis 
across the vertebrates line of evolution (Ankley et al., 1997). This provides an excellent basis 
for using results from fish tests to predict likely mechanisms of action of potential EDCs in 
other vertebrate. Moreover, much of the basic molecular machinery involved in initiation of 
toxic responses is highly conserved across vertebrate species.  
Different experimental approaches for partial- and full-life cycle tests with fish that 
enable the investigation of a broad range of EDCs have been described (Ankley and Johnson, 
2004). In the United States, the Environmental Protection Agency (EPA) uses the fathead 
minnow, in a short-term (21-day) assay. Chemicals identified as potential EDCs in the short-
term screening experiments might then be subjected to more intensive full-life cycle or even 
multigenerational assays with a number of vertebrate species. As model species fish such as 
the fathead minnow, Japanese medaka (Oryzias latipes), or sheepshead minnow (Cyprinidon 
variegatus) are included. From the international perspective, the OECD has formed a task 
group focused on developing internationally harmonised test methods for EDCs for both 
mammalian and nonmammalian species (Huet, 2000). A subcommittee within the task group 
is currently focusing specifically on fish tests. Three small fish species, i.e. fathead minnow, 
medaka, and zebrafish, are being evaluated for screening (partial-life cycle assays) as well as 
more extensive (full-life cycle) testing of EDCs (OECD, 2004).  
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Induction of VTG is used as a biomarker of exposure of fish to estrogenic substances, 
although standardised protocols are not yet available (Navas and Segner, 2006). Besides VTG 
there are also other biomarkers such as secondary sexual characteristics, gonadosomatic 
indices (GSI), plasma steroids, gonadal histology, enzyme induction, and gene expression. 
Hutchinson and colleagues (2006) consider that biomarker (nonadverse) signals provide 
mechanistic signals to guide chronic testing for adverse effects. At present, they are not 
recommended to be used to derive PNEC (predicted no-effect concentrations) values for 
EDCs. Adverse effects (survival, length, weight, development, fecundity fertilisation rate, 
hatching success) measure population-relevant parameters and should be used for calculating 
PNEC values for EDCs (Hutchinson et al., 2006). 
 
1.6. The IGF-system in bony fish 
 
In mammals, the insulin-like growth factor (IGF) system consists of IGF-I and IGF-II, cell 
surface receptors IGF-I (IGF-1R) and IGF-II (M-6-PR), high affinity binding proteins 
(IGFBP-1 to -6), IGFBP cleaving proteases, an acid labile subunit (ALS) which is a liver-
derived, growth hormone (GH)-regulated glycoprotein (Baxter and Martin, 1989), as well as 
several low-affinity IGFBP-related proteins. 
It has been recognized that the GH/IGF-I axis plays an integral role in the 
neuroendocrine regulation of vertebrate growth. As outlined in the “somatomedin 
hypothesis”, tissue secretions of IGF-I mediate the growth-promoting actions of pituitary GH 
by endocrine, paracrine, and/or autocrine mechanisms (Le Roith et al., 2001). At the cellular 
level, IGF-I triggers a variety of biological responses, such as proliferation, survival, 
migration, and differentiation. At the whole animal level IGF-I coordinates different cellular 
responses among the different tissues and cell types and regulates the pattern of growth.  
The existence of IGF-I signalling in fish was uncertain until the late 1980s. IGF-I 
activity was detected in the serum of both teleost and elasmobranchs, using a porcine cartilage 
sulfation bioassay (Shapiro and Pimstone, 1977). Duan and Hirano (Duan and Hirano, 1990) 
have demonstrated that human IGF-I could stimulate sulphate uptake in cultured explants of 
eel gill arch, and have reported a GH-dependent sulfation factor in the serum of the Japanese 
eel (Anguilla japonica) (Duan and Inui, 1990). Evidence for a functional IGF-I system 
(ligand, receptor and IGFBPs) in all known vertebrate groups indicates its long evolutionary 
history (Duan, 1998; Plisetskaya, 1998; Reinecke and Collet, 1998).  
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Vertebrate IGFs (IGF-I and IGF-II) are members of the insulin superfamily, that is 
characterized by a common “insulin-like” tertiary structure, conserved cystein residues and a 
hydrophobic core (Chan and Steiner, 2000). To date, IGF-like molecules have not been 
identified in any invertebrates, whereas distinct insulin and insulin-like genes have been 
shown to exist in urochordates (McRory and Sherwood, 1997; Reinecke et al., 1999), 
suggesting that the original “IGF-like” gene diverged from insulin-like ancestor after 
divergence of the protochordates from their invertebrate ancestor. The IGF-1R and the insulin 
receptor (InsR) likely evolved from a common ancestral gene (Wood et al., 2005). The 
structural similarities between the InsR, IGF-1R and their ligands provide the possibility for 
heterologous ligand-receptor interactions (Nakae et al., 2001). This potential cross activation 
has been proposed to explain the origin and evolution of the IGFBPs in vertebrates that 
exhibit a high affinity for IGFs, but little affinity for insulin (Kelley et al., 2002;2006). In 
addition, some IGFBPs seem to have evolved additional ligand-independent functions in 
mammals (Duan, 2002). 
 
1.6.1. Primary structure and mRNAs 
 
IGF-I gene sequences have been characterized in diverse teleost species, i.e. tilapia, 
Oreochromis mossambicus (Reinecke et al., 1997), the scorpaeniform daddy sculpin, Cottus 
scorpius (Loffing-Cueni et al., 1998), the salmonids coho salmon, Oncorhynchus kisutch (Cao 
et al., 1989; Duguay et al., 1992), rainbow trout, Oncorhynchus mykiss (Shamblott and Chen, 
1992), and chinook salmon, Oncorhynchus tshawytschwa (Wallis and Devlin, 1993), Japanese 
flounder, Paralychthys olivaceus (Tanaka et al., 1998), catfish, Clarias macrocephalus 
(McRory and Sherwood, 1997), goldfish, Carassius auratus (Kermouni et al., 1998), gilthead 
seabream, Sparus aurata (Duguay et al., 1996), Japanese eel, Anguilla japonica (Yamaguchi 
et al., 1999) and barramundi, Lates calcarifer (Kinhult, 1994). 
Teleost IGF-I cDNA sequences encoded preprohormones range between 159 and 193 
amino acids in length. All contain a putative signal peptide that is removed during secretion to 
yield the IGF-I prohormone of five domains (E-B-C-A-D) as also present in mammalian IGF-
I. The mature IGF-I peptide (domains B-C-A-D), contains 68 or 70 amino acids, depending 
on the species. Overall, mature teleost IGF-I peptides exhibit 72-81% identity to human IGF-
I, confirming that the IGF-I peptide has been well conserved throughout vertebrate evolution.  
 
 26
1.6.2. Expression patterns of IGF-I 
 
Evidence from molecular studies on fish indicates that the IGF-I gene is transcriptionally 
active throughout all stages of fish development, including embryogenesis. IGF-I mRNA 
expression has been demonstrated in unfertilized eggs, fertilized embryos, and larvae of 
gilthead seabream (Duguay et al., 1996), zebrafish  (Maures et al., 2002), and rainbow trout 
(Gabillard et al., 2003a), and in larva of barramundi (Stahlbom et al., 1999).  
A number of studies have demonstrated that IGF-I mRNA is expressed in multiple 
tissues of juvenile salmonids, including muscle, spleen, fat, intestine, liver, heart, testes, 
ovary, kidney, pituitary, and brain (Duguay et al., 1992; Shamblott and Chen, 1993; Biga et 
al., 2004). IGF-I mRNA expression has also been demonstrated in hepatic and nonhepatic 
tissues of adult teleosts, including several salmonids (Duguay et al., 1992; Duan et al., 1993a; 
Sakamoto and Hirano, 1993; Duguay et al., 1994) daddy sculpin (Loffing-Cueni et al., 1998), 
tilapia (Reinecke et al., 1997; Caelers et al., 2004). Schmid et al. (1999) investigated the 
expression of IGF-I mRNA in tilapia ovary; using in situ hybridisation, they demonstrated a 
moderate expression of IGF-I mRNA in the ooplasm of young oocytes, and higher levels of 
expression in somatic follicle cells (granulosa and theca) of oocytes at the yolk globule stage. 
IGF-I was immunocytochemically detected in various tissues of larva and/or juvenile shi 
drum (Radaelli et al., 2003), turbot (Berwert et al., 1995), and gilthead seabream (Perrot et al., 
1999). IGF-I has also been described in multiple tissues of adult tilapia and during early 
development, including somatic and germ cells of the gonads, in pancreatic endocrine cells, 
gastro-entero-endocrine cells, renal proximal tubule cells, interrenal cells, gill chondrocytes 
and chloride cells, skeletal muscles, cardiomyocytes, neurones (Reinecke et al., 1997; Schmid 
et al., 1999; Berishvili et al., 2006a; Berishvili et al., 2006b). Furthermore, IGF-I mRNA and 
peptide were located to subpopulations of endocrine cells in the adenohypophysis in 
developing and adult tilapia (Berishvili et al., 2006b; Eppler et al., 2007). 
 
1.6.3. Regulation of IGF-I expression 
 
There is abundant evidence that GH is the primary regulator of IGF-I synthesis and/or 
secretion in juvenile and adult fish. For example, GH injections have been shown to increase 
the hepatic IGF-I mRNA level in coho salmon (Cao et al., 1989; Duguay et al., 1994), 
rainbow trout (Sakamoto and Hirano, 1993; Shamblott et al., 1995), gilthead seabream 
(Duguay et al., 1996), tilapia (Shepherd et al., 1997), zebrafish (Maures et al., 2002) and carp 
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(Hashimoto et al., 1997). Plasma or serum levels of IGF-I and/or tissue responsiveness to 
IGF-I, have been demonstrated to be GH-dependent in a number of teleost species, including 
tilapia (Shepherd et al., 1997; Kajimura et al., 2001), eel (Duan and Hirano, 1992) and 
salmonids (Niu et al., 1993; Moriyama et al., 1994). Binding studies have confirmed the 
presence of high-affinity GH-binding sites in teleost liver (Shepherd et al., 1997). The 
existence of a functional (bidirectional) GH/IGF-I axis in fish is further supported by a 
number of in vivo and in vitro studies (Reinecke, 2006, compare Fig. 4). For example, GH 
stimulation of IGF-I mRNA expression has been shown to be dose-dependent in primary 
hepatocyte culture of coho salmon (Duan et al., 1993b; Pierce et al., 2004), rainbow trout 
(Shamblott et al., 1995) and tilapia (Schmid et al., 2000). Conversely, administration of IGF-I 
suppressed GH secretion in rainbow trout in vivo (Blaise et al., 1995), and from cultured 
tilapia pituitaries (Kajimura et al., 2002). 
Although most studies have focused on GH regulation of hepatic IGF-I expression, the 
stimulatory effects of GH are not only limited to the liver. GH injection has been shown to 
increase also the IGF-I mRNA levels in retina, brain, gill, and intestine of goldfish (Otteson et 
al., 2002; Vong et al., 2003), in gill and kidney of rainbow trout (Sakamoto and Hirano, 
1993), and in tilapia muscle (Kajimura et al., 2001). In agreement, high-affinity, saturable 
GH-binding sites have been identified in many nonhepatic tissues (Yao et al., 1991). 
 
1.6.4. IGF-I receptors (IGF-1R) and IGF-binding proteins (IGF-BPs) 
 
Full-length cDNA sequences encoding the IGF-1R have been reported in turbot (Elies et al., 
1999), zebrafish (Maures et al., 2002), and Japanese flounder (Nakao et al., 2002). In 
addition, partial IGF-1R cDNAs have been published for seabream (Perrot et al., 1999), 
rainbow trout (Greene and Chen, 1999), goldfish (Otteson et al., 2002) and Arctic charr (Tao 
and Boulding, 2003).  
The signal transduction pathways mediating IGF signalling through the IGF-1R 
include tyrosine kinase activity. The tyrosine kinase domains of both IGF-1Rs contain a 
number of conserved functional elements, including a putative ATP-binding site, a cluster of 
three tyrosine residues corresponding to the tyrosine phosphorylation site in the mammalian 
IGF-1R known to be required for IGF-1R signalling in mammals. The biological effects of 
IGF-1R activation are transduced by MAPK and PI3-kinase transduction pathways (Wood et 
al., 2005). IGF-1R mRNA is widely expressed among different fish species. The nearly 
ubiquitous distribution of IGF-1R mRNA was demonstrated in embryonic and adult zebrafish 
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(Ayaso et al., 2002; Maures et al., 2002), rainbow trout (Greene and Chen, 1999; Gabillard et 
al., 2003; Biga et al., 2004), seabream (Perrot et al., 1999), goldfish (Otteson et al., 2002), and 
Japanese flounder (Nakao et al., 2002). IGF-I binding was detected in retina, skeletal and 
cardiac muscle, ovary and brain of several species (Gutierrez et al., 1993; Blaise et al., 1995; 
Párrizas et al., 1995; Moon et al., 1996). 
Proteins with binding affinity and specificity for the IGFs have been identified in the 
serum of multiple teleosts (Degger et al., 2000; Kajimura et al., 2003; Shimizu et al., 2003a; 
Shimizu et al., 2003b; Beckman et al., 2004). In most fish species studied, IGF-I is observed 
to bind most abundantly to a protein of 40-45 kDa (Shimizu et al., 1999), similar in size to the 
IGFBP-3 to which the majority of IGFs are bound in mammals. Other IGFBPs detected in 
fish serum also exhibit similarities in size to mammalian IGFBPs, such as IGFBP-1 (29-31 
kDa), IGFBP-2 (30-32 kDa), and IGFBP-4 (21-24 kDa) (Kelley et al., 2006).  
 
1.7. Biological actions of the IGF system in fish 
 
The critical role of IGF-I as a primary regulator of somatic growth in fish is well illustrated by 
the stunted growth model. Transfer of yearling salmon from freshwater to seawater before 
physiological completion of smoltification results in significant growth retardation (Wood et 
al., 2005). Stunted fish exhibited elevated levels of serum GH when compared with normally 
growing fish. The reduced expression of hepatic IGF-I mRNA was associated with a reduced 
level of circulating IGF-I protein (Duan et al., 1995). IGFBP-3 was increased under anabolic 
circumstances, whereas lower molecular weight IGFBPs (IGFBP-1, -2, -4) were upregulated 
in catabolic phases, e.g. fasting (Kelley et al., 2001). The homolog to mammalian IGFBP-3 
appears to facilitate IGF-I signalling in teleost, perhaps by prolonging the half-life of IGF-I, 
while lower molecular weight IGFBPs are thought to suppress IGF-I-mediated growth by 
inhibiting activation of the IGF-1R.  
Human IGF-I and recombinant teleost IGF-I peptide exhibited equal potency in 
stimulating sulfation activity in cartilage explants of salmon and seabream (Fine et al., 1997). 
Similar effects have been reported in other teleost fish, including tilapia (Ng et al., 2001), carp 
(Cheng and Chen, 1995), and rainbow trout (Takagi and Bjornsson, 1996). IGF-I has potent 
mitogenic effects in a variety of tissues and cell types. For example, recombinant human IGF-
I potently stimulated [3H]thymidine incorporation into eel cartilage (Duan and Hirano, 1992), 
rainbow trout myoblasts, spermatogonia, and spermatocytes (Loir and Le Gac, 1994), and 
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zebrafish embryonic cells (Duan et al., 1999). There is abundant evidence that IGF-I 
stimulates protein synthesis in fish organs. For example, recombinant human IGF-I stimulated 
L-alanine uptake in rainbow trout myocytes (Castillo et al., 2004), and both L-alanine uptake 
and L-leucine incorporation in brown trout cardiomyocytes (Gallardo et al., 2001). 
There is evidence suggesting the functional impact of IGF signalling during early 
development in fish. For example, coexpression of mRNAs encoding IGF ligands and 
receptors has been reported in zebrafish embryos, and also the presence of proteins 
corresponding to functional IGF receptors (Maures et al., 2002). Our group has investigated 
the cellular sites of IGF-I mRNA and peptide synthesis in the early developing tilapia (0-140 
days post fertilization, DPF). IGF-I appeared early (4-5 DPF), first in liver, the main source of 
endocrine IGF-I, and then in organs involved in growth or metabolism, i.e. liver, exocrine and 
endocrine pancreas, chondrocytes, skeletal muscle cells, neurohypophysis and 
adenohypophysis (Berishvili et al., 2006b). The expression of IGF-I was more pronounced 
during development than in juvenile and adult life. Local IGF-I therefore seems to have a high 
functional impact in early growth, metabolism and organogenesis. Targeted knockdown of the 
duplicate IGF-1Rs in zebrafish embryos by morpholino-modified oligonucleotides resulted in 
dramatic developmental perturbations and even death, indicating distinct requirements for 
IGF signalling during embryonic development (Schlueter et al., 2003).  
The GH/IGF-I system has been long recognized as an important participant in the 
osmoregulatory physiology of fish. McCormick and colleagues were among the first to 
demonstrate that exogenous administration of IGF-I to salmonids improved their ability to 
maintain plasma osmolality and sodium levels during seawater challenge (McCormick et al., 
1991). Subsequent studies showed that IGF-I stimulated gill Na+, K+,-ATPase activity, 
indicating a direct effect of IGF-I on osmoregulation in salmonids (Madsen and Bern, 1993). 
Transfer of seawater-adapted tilapia to freshwater resulted in reduced growth and decreased 
tissue levels of GH and IGF-I mRNA, but increased serum levels of GH and IGF-I, 
suggesting that osmoregulatory stress may directly activate the GH/IGF-I axis without any 
concomitant stimulation of somatic growth (Riley et al., 2003). 
Fish are convenient models to investigate gonadal development and function, and 
studies have indicated an important role of the IGF-I system in fish reproductive 
development. Fish gonads express mRNAs encoding IGFs (Duguay et al., 1992; Duan and 
Plisetskaya, 1993; Duguay et al., 1994; Perrot et al., 2000; Berishvili et al., 2006a), the IGF-
1R (Perrot et al., 2000; Maures et al., 2002), and IGFBPs (Funkenstein et al., 2002). IGF-I has 
been localized in the ovary of tilapia (Schmid et al., 1999), carp (Gutierrez et al., 1993), and 
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in rainbow trout spermatogonia and spermatocytes (Loir and Le Gac, 1994). IGF-I signalling 
has been shown to influence the synthesis and/or secretion of reproductive steroid hormones 
from the fish gonadal tissues. For example, both human and recombinant salmon IGF-I have 
been shown to inhibit basal and LH-stimulated testosterone and 17α-hydroxyprogesterone 
production by isolated theca-interstitial cells from coho salmon preovulatory follicles. In 
addition, IGF-I stimulated production of 17β-estradiol and 17,20β-progesterone (17,20 β-P) 
by granulosa cells from prematurational follicles, and of 17,20 β-P by granulosa cells from 
maturational follicles (Maestro et al., 1997). Recombinant IGF-I alone had no effect on 
spermatogenesis by Japanese eel testicular fragments, but enhanced the stimulatory effects of 
11-ketotestosterone (Nader et al., 1999).  
 
1.8. Influence of endocrine disruptors on the fish IGF system 
 
Thus, IGF-I plays a central role in the complex system that regulates fish growth, 
differentiation, and reproduction. It selectively promotes mitogenesis and differentiation and 
inhibits apoptosis (Jones and Clemmons, 1995; Reinecke and Collet, 1998). Among the non-
mammalian classes, bony fish are the mostly studied with respect to IGF-I (Duan, 1998; 
Plisetskaya, 1998; Reinecke et al., 2005; Wood et al., 2005) mainly due to their unique 
development from the larval to the adult life and to their high importance in aquaculture. 
Thus, there is rising interest in the significance of IGF-I in fish development, growth and 
reproduction. Some evidence has been presented (Riley et al., 2004; Carnevali et al., 2005; 
McCormick et al., 2005) that estrogens may influence acutely synthesis and/or release of IGF-
I from adult fish liver and affect sulfate uptake into cultured cartilage (Ng et al., 2001). Very 
recently, the influence of exposure to E2 on several genes, including IGF-I, has been 
investigated in an adult cyprinid, the fathead minnow (Filby et al., 2006). Thus, there is some 
evidence that organisational effects of estrogens on growth and reproduction of fish may be 
mediated via IGF-I. These effects may be even more pronounced during fish development, the 
phase of most rapid growth, sexual differentiation and gonad development. 
A direct effect of BPA on osteoclasts and osteoblasts has been shown in a culture 
system of goldfish scales (Suzuki and Hattori, 2003), using tartrate-resistant acid phosphatase 
(TRAP) and alkaline phosphatase (ALP) as markers for osteoclasts and osteoblasts, 
respectively. BPA at 10-5 M significantly suppressed both TRAP and ALP activities in vitro 
and in vivo and decreased the expression of IGF-I mRNA. However, E2 stimulated TRAP and 
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ALP activities and did not alter IGF-I mRNA expression, suggesting that BPA and E2 may 
differently affect bone metabolism (Suzuki and Hattori, 2003). Furthermore, BPA more 
pronouncedly interacted with local IGF-I in bone than E2. 
A further physiological process in fish where estrogens and xenoestrogens may 
interfere with the GH/IGF-I system is smoltification, i.e. the developmental stage through 
which the stream-dwelling parr is transformed into the seaward migrating smolt. Here GH 
plays a central role likely both by direct and indirect action, the latter being mediated via 
endocrine or local IGF-I on the expression of gill Na+, K+-ATPase. Recent evidence indicates 
that the role of IGF-I in smoltification can be modulated by estrogens. E2 (100 ng/L) and 4-
nonylphenol (20  μg/L) significantly reduced plasma IGF-I by about 25% in Atlantic salmon 
during smoltification (Arsenault et al. 2004), and it has been assumed that environmental 
xenoestrogens such as 4-nonylphenol have contributed to the historical decline of anadromous 
salmons in Eastern Canada (Fairchild et al., 1999). 
Thus, to date only few studies have addressed the question of possible interferences 
between EDCs and the IGF-I system of fish. Provided that the preliminary data are 
strengthened by further studies, E2 and estrogenic compounds must be considered to have a 
higher impact as endocrine disruptors as yet thought because they interfere with a key 
hormonal system that is involved in numerous processes of metabolism, reproduction, 
differentiation, growth, development and ageing. 
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1.9. Aim of the study 
 
The present study aims to investigate the potential influence of EE2, as representative potent 
estrogen, on IGF-I when applied to developing male and female fish.  
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Fig. 4 The GH-IGF-I axis in teleost fish (Scheme modified from Reinecke, 2006). 
 
For that purpose, two experimental approaches were selected: 
1. A balanced population of tilapia (Oreochromis niloticus) was fed during 10-40 DPF 
with EE2 at the optimal dosage to induce functional feminisation. This period represents the 
sensitive window of gonad differentiation in tilapia (Fig. 5). We assessed whether EE2 
treatment during this development stage exerts lasting effects on gonad differentiation, 
growth, ER expression and crucial issues of the GH/IGF-I system. The following parameters 
were determined after termination of EE2 treatment at 50, 75, 90 and 165 DPF: sex ratio, 
growth, serum IGF-I levels, and mRNA expression levels of IGF-I, GH and ERα. 
Furthermore, we studied the potential alterations of IGF-I mRNA expression in the organ-
specific cells of the organs investigated after EE2 treatment by in situ hybridisation.  
The target organs studied included those of the central GH/IGF-I axis, i.e. pituitary 
and liver. Although fish liver is the major source of circulating IGF-I, IGF-I also occurs in 
extrahepatic sites (Reinecke et al., 1997) where it is particularly expressed during 
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development (Duguay et al., 1996; Perrot et al., 1999; Radaelli et al., 2003; Berishvili et al., 
2006b). Thus, the alterations in IGF-I mRNA expression were also determined in organs 
showing high IGF-I expression during ontogeny, i.e. gills and brain. We further examined the 
influence of EE2 exposure on ERα and IGF-I expression in the gonads. Gonad differentiation 
of developing fish can be altered by estrogen treatment (Segner et al., 2006), and gonads of 
developing fish express IGF-I mRNA (Berishvili et al., 2006a), although the functional role of 
IGF-I expression in the gonad, and its response to estrogen exposure are unknown yet.  
2. In a second approach, developing fish were exposed to environmental 
concentrations of EE2 starting from 10 DPF until end of experiment (100 DPF). This period 
includes the sensitive window of gonad differentiation in tilapia (Fig. 6). We assessed whether 
EE2 treatment at environmental concentrations exerts effects on gonad differentiation, 
growth, ER expression and crucial issues of the GH/IGF-I system. The following parameters 
were determined at 30, 50, 75 and 100 DPF: sex ratio, growth and mRNA expression levels of 
IGF-I, and ERα in liver, gonads, gills and brain.  
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2. Material and Methods 
2.1. Production and maintenance of fish 
 
The Oreochromis niloticus fry, used in this study, originated from the Aquaculture 
Experimental Facilities of CIRAD (Montpellier). Fertilized eggs were obtained through either 
natural or artificial fertilisation (Berishvili et al., 2006a).  
For natural fertilisation, O. niloticus breeders (1 male and 3 females) were maintained 
in a spawning aquarium of 360 L maintained at constant temperature (27°C) and photoperiod 
(12light:12dark). Under natural photoperiods, reproductive activity occurs mainly from the 
afternoon until sunset in these species (Baroiller et al., 1997). Consequently, we checked 
every morning for the presence of newly incubating females, which were then isolated from 
the other fish. On the first day after fertilization, eggs were gently removed from the mouth of 
the female and incubated in 1L McDonald jars at 27±1°C (mean range).  
For artificial fertilisation, the maturation of isolated females was carefully recorded 
(i.e. uro-genital papilla development and behaviour). When the near-breeding stage was 
reached, both male and female breeders were striped under anaesthesia. Fertilisation was 
performed according to (Chourrout and Itskovich, 1987). After fertilisation, eggs were 
incubated in 1L McDonald jars, maintained at 27°C, to the free-swimming stage (around 10 
DPF).  
 
2.2. Hormone treatment with high concentration of EE2 
 
Just before the completion of yolk sac absorption, fry were placed into a 40L tank in an 
indoor recirculating system at 27 ± 1°C. Three natural populations (n=200 each) of tilapia were 
fed in September during a period covering the sensitive period, i. e. 10-40 DPF with EE2 at the 
optimal dosage (125 μg EE2/g food) to induce functional feminisation in most individuals. 
Hormonally treated commercial salmonids food was prepared by the ethanol evaporation 
method (0.6 L of 95% ethanol/kg food). EE2 (Sigma E-4876, Switzerland) was dissolved in 
95% ethanol and the solution sprayed over the food (125 μg EE2/g food). Control food was 
prepared in the same way without EE2. After ethanol evaporation, the food was stored at 4°C. 
Fry were fed at 20% of their biomass per day for the first week, 15% for the second week, 12% 
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for the third week and 10% for the last week. They were fed six times daily. Starting from 41 
DPF both populations were fed with normal salmonid food until sampling (Fig. 5).  
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Fig. 5 Developmental stages of tilapia and hormone treatment with high concentration of EE2 (kindly provided by 
Dr. Baroiller, Montpellier).  
 
At the age of 50, 75, 90 and 165 DPF, fish were sampled and those from 75, 90 and 165 DPF 
additionally used for histologic sex determination to evaluate statistically feminisation 
efficiency. Control (male: 50 DPF n=12, 75 DPF n=9, 90 DPF n=9, 165 DPF n=9; female: 50 
DPF n=15, 75 DPF n=12, 90 DPF n=14, 165 DPF n=12) and EE2-treated (male: 50 DPF n=12, 
75 DPF n=10, 90 DPF n=12, 165 DPF n=11, female: 50 DPF n=12, 75 DPF n=12, 90 DPF 
n=14, 165 DPF n=11) tilapia were sampled. Blood samples were obtained from control (male: 
75 DPF n=7, 90 DPF n=6, 165 DPF n=9; female: 75 DPF n=7, 90 DPF n=7, 165 DPF n=12) 
and EE2-treated (male: 75 DPF n=7, 90 DPF n=6, 165 DPF n=7; female: 75 DPF n=8, 90 DPF 
n=8, 165 DPF n=9) tilapia. 
 
2.3. Hormone treatment with environmental concentrations 
 
Two monosex populations XX and XY (n=300 each) of tilapia were artificially fertilised. In 
our study, we have used so-called monosex populations of tilapia. As histologically assessed 
 36
during the sampling procedure, the percentage of females in the female monosex group 
amounted to about 76% and that of males in the male monosex group to 80%. A population 
with 75% or more fish of the same sex is considered to be monosex (D’Cotta et al., 2001). 
Thus, our percentage is well within the range that can be achieved in tilapia (Baroiller et al., 
1995) because sex chromosome–linked genetical factors determine sex largely but not 
exclusively, and the development of final sex phenotype is influenced by autosomal genetic 
factors in combination with the hormonal, behavioral, and environmental cues (Baroiller et 
al., 1999; Devlin and Nagahama 2002). For experimentation fish were transferred to the 
aquaria from 1L McDonald jars around 10 DPF just before the completion of yolk sac 
absorption and incubated in 40L aquaria at 27 ± 1°C during a period of 10-100 DPF at the 
concentrations 5 ng/L EE2, 25 ng/L EE2 and solvent control, respectively. Each group was 
run in duplicate aquaria, saturated prior treatment experiment with EE2 at concentration of 
1000 ng/L during one week. Fish were fed with commercial salmonid food at 20% of their 
biomass per day for the first week, 15% for the second week, 12% for the third week and 10% 
for the last week. They were fed six times daily. 
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Fig. 6. Developmental stages of tilapia and treatment with environmental concentrations of EE2 (kindly provided 
by Dr. Baroiller, Montpellier). 
 
At the age of 30, 50, 75 and 100 DPF fish were sampled and those from 75, 90 DPF 
additionally used for sexing statistics to evaluate feminisation efficiency. Control (male: 30 
 37
DPF n=8, 50 DPF n=12, 75 DPF n=11, 100 DPF n=12; female: 30 DPF n=10, 50 DPF n=10, 
75 DPF n=11, 100 DPF n=12) and EE2-exposed (5 ngEE2/L, male: 30 DPF n=8, 50 DPF n=8, 
75 DPF n=7, 100 DPF n=8; female: 30 DPF n=9, 50 DPF n=8, 75 DPF n=10, 100 DPF n=8; 25 
ngEE2/L, male: 30 DPF n=7, 50 DPF n=7, 75 DPF n=8, 100 DPF n=8; female: 30 DPF n=7, 
50 DPF n=8, 75 DPF n=9, 100 DPF n=8). 
 
2.4. Solid phase extraction/ELISA 
 
Ethinylestradiol ELISA kit (Ecologiene, Japan, purchased from Biosense Laboratories, 
Norway) was used for EE2 detection in water samples. In order to concentrate EE2 content to 
the detectable limits of the assay, water samples were prepared by solid phase extraction 
(SPE), according to Ternes et al. (Ternes et al., 1999). For this purpose, 100 mg LiChrolut® 
EN and 200 mg RP-18 cartridges (Merck) were first conditioned with the series of passing - 
Hexane, Acetone, Methanol and water pH 3.0. Pre-filtered water samples (200 mL) were 
loaded under a gentle vacuum pressure (1L/1h). Loaded cartridges were dryed under a 
nitrogen flow for 45-60 min. Elution was performed with 4 mL aceton, in silanised amber 
vials (Supelco) to collect the eluent. Aceton was evaporated to dryness under a stream of 
nitrogen and EE2 was reconstituted in 0.5 mL ethanol. Resulting samples were analysed by 
ELISA. The procedure was done according to the manufacturer’s instructions. 
 
2.5. Fish tissue preparation 
 
Fish were anaesthetised with 2-phenoxy-ethanol (Sigma) added to water and measured in 
weight and length. Blood was collected with one mL heparinised syringes, centrifuged for 15 
min at 4°C at 10000 rpm, serum was collected and stored at -20°C until use. Tissue specimens 
(liver, brain, gonads, gills, pituitary) were excised and immediately transferred into 1.5 mL of 
RNAlaterTM (Ambion, Austin, TX, USA), kept overnight at 4°C to allow RNAs inhibitors to 
act and lateron stored at -20°C until use. Specimens for in situ hybridisation were fixed in 
Bouin’s solution without acetic acid for 4 h at room temperature, dehydrated in ascending 
series of ethanol and routinely embedded in paraplast (58°C).  
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2.6. Radioimmunoassay for IGF-I 
 
Serum IGF-I levels were determined in undiluted samples by RIA after SepPak C18 
chromatography (Waters Corp., Milford, MA, USA), as described earlier (Zapf et al., 2002). 
In brief, for determination of serum IGF-I, 0.15 mL PBS containing 0.2% human serum 
albumin (HSA), pH 7.4, were added to 0.1 mL serum. For determination of pancreatic IGF-I, 
0.5 mL of the extract was lyophilised, dissolved in 0.25 mL of PBS/0.2% HSA and 
centrifuged. All samples were acid-treated and run over SepPak C18 cartridges according to 
the protocol supplied by Immunonuclear (Stillwater, MN, USA). After reconstitution with 1 
mL PBS/0.2% HSA samples were assayed at three different dilutions (1:5, 1:10, 1:20). 0.2 
mL of samples or standards (tilapia IGF-I from GroPep, Adelaide, Australia) and 0.1 mL of 
IGF-I antiserum (final dilution 1:20000) were preincubated for 24 h at 4°C. 25000-35000 cpm 
of 125I-IGF-I (Anawa, Wangen, Switzerland, specific activity 300-400 μCi/μl) were added to 
the final incubation volume (0.4 mL). The reaction mixture was incubated for another 24 h 
before precipitation with goat anti-rabbit gammaglobulin antiserum. After centrifugation, the 
pellet was counted in a gamma-counter. 
 
2.7. Design of primers and probes for real-time PCR 
 
Based on the mRNA sequences of Oreochromis mossambicus IGF-I (Reinecke et al., 1997), 
and O. niloticus β-actin as a a house-keeping gene (Hwang et al., 2003) primers (ß-actin: 
sense GCCCCACCTGAGCGTAAATA, antisense AAAGGTGGACAGGAGGCCA; IGF-I: 
sense TCTGTGGAGAGCGAGGCTTT, antisense CACGTGACCGCCTTGCA) and probes 
(ß-actin: TCCGTCTGGATCGGAGGCTTCATC; IGF-I: 
ATTTCAATAAACCAACAGGCTATGGCCCCA) were created as already described 
(Caelers et al., 2004). Using this method new primers and probes for GH (Caelers et al., 2005) 
and ERα (sense CAAGTGGTGGAGGAGGAAGATC, antisense 
CTCAGCACCCTGGAGCAG, probe CTGATCAGGTGCTCCTC) based on O. niloticus GH 
(Ber and Daniel, 1992) and ERα sequences (Chang et al., 1999) were designed with Primer 
Express software version 1.5 (PE Biosystems, Foster City, CA, USA). ERα was selected since 
it is considered to be the strongest indicator for response of the estrogen system to challenge 
with estrogen in teleosts (Filby and Tyler, 2005). The internal probes were labelled at the 
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5’end with the reporter dye 6-carboxyfluorescein (FAM), and at the 3’end with the quencher 
dye 6-carboxytetramethyl-rhodamine (TAMRA, both Eurogentec, Herstal, Belgium). Primer 
accuracy was verified by RT-PCR, the products were sequenced, and the integrity assured on 
a 2.5 % agarose gel. 
 
2.8. Quantitation of IGF-I, GH, and ER-α expression by two-step real-time RT-PCR 
TaqMan system 
 
Total RNA was extracted from specimens stored in 1.5 mL of RNAlaterTM using TRIzolTM 
reagent (Invitrogen, Merelbeke, Belgium) and treated with 1 U of RQ1 RNAse-free DNAse 
(Catalys AG, Wallisellen, Switzerland). cDNA was synthesized from 800 ng of total RNA 
using 1 x TaqMan® RT Buffer, MgCl2 (5.5 mM), 1.25 U/µl of MuLV reverse transcriptase, 
2.5 µM of random hexamers primers, 0.4 U/µl ribonuclease inhibitor, 500 µM each dNTP 
(Applied Biosystems, Rotkreuz, Switzerland) for 10 min at 25˚C, 30 min at 48˚C and 5 min at 
95˚C. 2µl of cDNA obtained from 10 ng/µl total RNA were subjected, in duplicates, to real-
time PCR using a AbsoluteTMQPCR low ROX Mix (ABgene, UK) including Thermo-Start® 
DNA Polymerase, 300 nM of each primer, 150 nM of the fluorogenic probe. Amplification 
was performed using a total reaction volume of 10 μl in a MicroAmp Fast Optical 96-well 
reaction plate (Applied Biosystem). Reactions were run on the ABI 7500 Fast Real-Time PCR 
System (Applied Biosystems) with the following thermal conditions: 95˚C for 15 min for 
enzyme activation followed by 40 cycles of 95˚C for 15 sec and 60˚C for 1 min. 
 
2.9. Relative quantification of treatment effects using the ΔΔCT method 
 
The comparative threshold cycle (ΔΔCT) method (Livak and Schmittgen, 2001) was used to 
calculate relative gene expression ratios between EE2-treated and control groups. Data were 
normalized to β-actin as the reference gene. Efficiency tests for β-actin and IGF-I assays 
(Caelers et al., 2004) and ERα assay (data not shown) permitted the accurate use of the ΔΔCT 
method. Relative changes induced by EE2-feeding were calculated by the formula 2− ΔΔCT, 
with ΔΔCT = ΔCT (treated group) – ΔCT (untreated control), and ΔCT = CT (target gene) – CT 
(reference gene). All data are expressed as n-fold changes of gene expression in the 
experimental group relative to the control group, displayed in the graphs as 2 log scale, a 
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common way of presenting qPCR data, (Dzidic et al., 2006). Statistical significance was 
calculated using the nonparametric Mann-Whitney rank sum test (Mann and Whitney, 1947), 
which was selected as suitable variance analysis test. Exact P value is calculated. Statistical 
analyses were performed with GraphPad Prism© 4. 
 
2.10. Preparation of probes for in situ hybridisation 
 
Probes used for in situ hybridisation were prepared as already described (Schmid et al., 1999; 
Berishvili et al., 2006a; Berishvili et al., 2006b). In brief, total RNA from tilapia liver was 
extracted by the phenol/chloroform method (Chomczynski and Sacchi, 1987) with the 
Ultraspec Extraction Kit (ams, Lugano, Switzerland). For cDNA synthesis 5 µg RNA were 
annealed with 1 µM of a poly(dT) primer (5' CCTGAATTCTAGAGCTCAT(dT17) 3') for 3 
min at 70°C. The RNA/primer mix was incubated for 1 h at 37°C with 15 mM dNTPs and 10 
U AMV-RTase (Pharmacia, Switzerland) in 1x reaction buffer (50 mM Tris-HCl/pH 8.3, 40 
mM KCl, 6 mM MgCl2). One µl cDNA was incubated with 1 µM of sense (5`-
GTCTGTGGAGAGCGAGGCTTT-3`) and antisense (5’-
AACCTTGGGTGCTCTTGGCATG-3`) primers corresponding to the B- and E- domain, 200 
µM dNTPs, and 1U Taq-polymerase (Pharmacia) in 1x incubation buffer (10 mM Tris-
HCl/pH 8, 50 mM KCl, 1.5 mM MgCl2, 0.001 % gelatine). The amplification program was 
optimised for a Stratagene RoboCycler Gradient 40: 1 cycle 10 min at 94°C, 1 min at 59°C, 2 
min at 72°C; 30 cycles 1 min at 94°C, 1 min at 59°C and 2 min at 72°C followed by final 
extension of 5 min at 72°C. PCR fragments were separated on a 2% agarose gel and eluted by 
the Gel Extraction Kit QIAquick (Qiagen, Switzerland). Thereafter, the PCR products were 
cloned in a pCR-Script SK(+) cloning vector using a kit (Stratagene, Heidelberg, Germany). 
Plasmids containing the gene sequence fragments were sequenced (Microsynth, Switzerland) 
and the sequences compared to database. The plasmids containing the specific inserts of IGF-I 
(207 bp) were used as templates for the synthesis of digoxigenin (DIG)-labelled RNA probes. 
Linearisation was performed with EcoRI for T3- and NotI for T7-polymerase-driven 
transcription. One µg of linearised plasmids was transcribed in vitro in the presence of DIG-
UTP from T3 and T7 promotors to obtain antisense and sense probes. Integrity of probes and 
efficiency of labelling were confirmed by dot blot and gel electrophoresis including blotting 
and incubation with antibody. 
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2.11. In situ hybridisation protocol 
 
Four µm sections on Super Frost Plus slides (Menzel-Gläser, Germany) were dewaxed in 
Xylol, rehydrated in descending series of ethanol (100%, 96%, 70%), and postfixed with 4% 
paraformaldehyde and 0.1% glutaraldehyde in 1 x PBS. The following steps were carried out 
with diethyl pyrocarbonate-treated solutions in a humified chamber: to denaturate proteins, 
sections were digested with 0.02% proteinase K in 20 mM Tris-HCl/pH 7.4, 2 mM CaCl2 for 
10 min at 37°C and, to reduce background, treated with 1.5% triethanolamine and 0.25% 
acetic anhydride for 10 min at room temperature. Slides were incubated with 100 µl 
prehybridisation solution/section for 3 h at 54°C. Hybridisation was carried out overnight at 
54°C with 50 µl of hybridisation buffer containing 200 ng of sense (negative control) or 
antisense probes previously denaturated for 5 min at 85°C. Slides were washed for 15 min at 
room temperature in 2 x SSC, and for 30 min at 54°C at descending concentrations of SSC (2 
x, 1 x, 0.5 x, 0.2 x). Sections were incubated with alkaline phosphatase-coupled anti DIG 
antibody diluted 1:4000 in 1% blocking reagent in buffer P1 for 1 h at room temperature in 
the dark. After washing twice in buffer P1 for 15 min, sections were treated with buffer P3, 5 
mM levamisole and NBT/BCIP stock solution. Colour development was performed overnight 
at room temperature and stopped by rinse of the slides in tap water for 15 min. Thereafter, 
sections were mounted with glycergel. Microscopy and photography were performed with a 
Zeiss Axioscope using the Axiovision 3.1 software (Zeiss, Zürich, Switzerland).  
Specificity as previously demonstrated for adult tilapia male and female gonads (Schmid et 
al., 1999; Berishvili et al., 2006b) and liver (Schmid et al., 1999) was reassured on adjacent 
sections of 50 DPF male brain with IGF-I antisense (Fig. 7A) and sense (Fig. 7B) probes and 
gills.  
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In situ hybridisation revealed positive signals with the antisense probe whereas no signals 
were present in the negative controls.   
 
 
Fig. 7 Specificity of the in situ hybridisation technique shown on two adjacent sections of 50 DPF male tilapia 
brain hybridized with an IGF-I antisense probe (A) and an IGF-I sense probe (B).  
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3. Results 
3.1. Treatment effects of EE2 
 
Both, high-dose and environmental concentrations of EE2 strongly impacted the GH/IGF-I 
axis in tilapia and exerted persiting effects.  
 
3.2. High dose EE2 treatment  
 
Treatment of developing tilapia with high dose EE2 was performed as described (Shved et al., 
2007). 
 
3.2.1. Sex ratio 
 
After EE2 treatment the sex ratio had shifted from 47.2 ± 8.5% females in control to 86.5 ± 
14.1% at 165 DPF. 
 
3.2.2. Body length and weight 
 
EE2 treatment caused a progressive decrease in body length (BL) and body weight (BW) in 
both sex (Fig. 8). Both parameters were significantly lowered from 90 DPF onwards (90 DPF 
- BL: -16.9% in males, -13.4% in females; BW: -47.4% in males, -32.3% in females; 165 
DPF - BL: -19.5% in males, -15.2% in females; BW: -46.2% in males, -40.1% in females). 
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Fig. 8 Influence of EE2 exposure on fish growth throughout the experimental period. Body length (A,B, in cm) 
and weight (C,D, in g) in male (A,C) and female (B,D) control (white columns) and EE2-treated (black columns) 
tilapia. X-axis is labelled as DPF. Columns give mean values and bars SD. Significance levels: * P <0.01, ** 
P<0.005, *** P<0.0005. 
 
3.2.3. Serum IGF-I level  
 
While at 50 DPF the fish were too small to allow blood drawing blood could be taken at 75, 
90 and 165 DPF. At 75 DPF, in males (Fig. 9G) the IGF-I serum level was significantly (P = 
0.002) decreased in the EE2-treated group (5.65 ± 1.18 ng/mL) when compared to the 
controls (9.70 ± 2.06 ng/mL) while in females (Fig. 9H) there was only a trend to reduce IGF-
I serum level (control 11.20 ± 2.18 vs. EE2-treated 8.54 ± 2.26, P=0.08). At the later stages, 
there was no significant difference between the treated group and the controls (Fig. 9G,H). 
 
3.2.4. IGF-I mRNA and ERα mRNA levels in liver 
 
Hepatic IGF-I mRNA was significantly reduced by EE2-feeding with the effect becoming 
evident in females (Fig. 9C) later than in males (Fig. 9A). At 50 DPF, IGF-I mRNA in liver 
was lowered in males by the 7.1-fold (P=0.05), at 75 DPF in males by the 3-fold (P=0.01) and 
in females by the 2.7-fold (P=0.002), at 90 DPF in males by the 1.7-fold (P=0.02) and in 
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females by the 5-fold (P=0.0003) and almost recovered in both sex at 165 DPF (Fig. 9A,C). In 
situ hybridisation revealed a markedly reduced number of hepatocytes containing IGF-I 
mRNA after EE2 treatment at 50 (Figs. 9E,F) and 75 DPF in male liver and at 75 and 90 DPF 
in female liver. Hepatic ERα mRNA was significantly increased after EE2-feeding to the 6.1-
fold in males (P=0.01) and the 2.6-fold (P=0.004) in females at 50 DPF (Fig. 9B,D). At 75 
DPF, ERα mRNA was raised to the 2.2-fold in males (P=0.02) and the 37-fold in females 
(P=0.002). In male liver, ERα was back at the normal level at 90 DPF. In female liver, ERα at 
90 DPF was still raised to the 2.5-fold (P=0.05) of the control mRNA and at about the normal 
level at 165 DPF. 
 
Fig. 9 Influence of EE2 exposure on IGF-I and ERα gene expression in liver and on IGF-I peptide levels in 
serum. (A-D) Relative changes (log 2) of IGF-I (A,C) and ERα (B,D) mRNA expression in EE2-treated tilapia 
as compared to age-matched control tilapia. (E,F) In situ hybridisation with IGF-I antisense probe of tilapia liver 
specimens in 50 DPF old control (E) and EE2-treated (F) male tilapia. White arrows point to IGF-I mRNA-
expressing hepatocytes. (G,H) IGF-I peptide concentrations in serum determined by a fish-specific RIA in 
control (white columns) and EE2-treated (black columns) male (G) and female (H) fish. X-axis is labelled as 
DPF. Columns give mean values and bars SD. Significance level: * P=0.05, P=0.02, P=0.01; ** P=0.002, 
P=0.004; *** P=0.0003. 
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3.2.5. IGF-I mRNA and ERα mRNA levels in brain 
 
In male brain, no significant change in the expression of IGF-I mRNA was detected 
throughout the experimental period (Fig. 10A). In female brain, however, at 75 DPF IGF-I 
mRNA was significantly (P= 0.001) reduced (3.45-fold). At 90 and 165 DPF, IGF-I mRNA 
was about the normal level (Fig. 10C).  
At 75 DPF, in all regions of the female brain (Fig. 10F) the number of neurones showing IGF-
I mRNA was largely reduced when compared to control (Fig. 10E). Brain ERα mRNA 
exhibited no significant changes at any experimental stage (Fig. 10B,D). 
 
 
 
Fig. 10 Influence of EE2 exposure on IGF-I and ERα gene expression in brain. (A-D) Relative changes (log 2) 
of IGF-I (A,C) and ERα (B,D) mRNA expression in EE2-treated as compared to age-matched control tilapia. 
(E,F) In situ hybridisation with IGF-I antisense probe of tilapia brain specimens in 75 DPF old control (E) and 
EE2-treated (F) female tilapia. In the cell body layer of the periventricular zone (cPZ) and the tectum opticum 
(TeO) the number of IGF-I mRNA expressing neurons (black arrows) is largely reduced in the EE2-treated brain 
(F). X-axis is labelled as DPF. Columns give mean values and bars SD. Significance level: ** P= 0.001. 
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3.2.6. IGF-I mRNA and ERα mRNA levels in male and female gonads 
 
No alteration in the expression of IGF-I was detected at 50 DPF (Fig. 11A,C). At 75 DPF, 
there was a significant (P=0.015) decrease (- 2.2-fold) in the IGF-I mRNA level in the female 
gonad and at 90 DPF a significant (P=0.0013) reduction (- 2.5-fold) of IGF-I mRNA in the 
male gonad. At the later stages, IGF-I mRNA reached the normal level. In situ hybridisation 
of male gonad at 90 DPF revealed that the number of IGF-I mRNA containing spermatogonia 
was markedly lower in EE2-treated (Fig. 11F) fish than in control (Fig. 11E). Less IGF-I 
mRNA signals were observed in granulosa cells of the ovaries in EE2-treated fish at 75 DPF 
(Fig. 11H). Furthermore, IGF-I mRNA in small oocytes as present in controls (Fig. 11G) was 
largely reduced. In the male gonads, a significant raise in ERα mRNA was found at 50 DPF 
(4.4-fold, P=0.015), 75 DPF (4.2-fold, P=0.028) and 90 DPF (2.6-fold, P=0.009) (Fig. 11B). 
In contrast, in the female gonad, a significant (P=0.015) increase in ERα mRNA was obtained 
only at 50 DPF by the 1.78–fold followed by a significant decrease (-1.79-fold, P=0.006) at 
75 DPF. At 90 DPF, there was only a tendency (P=0.11) to decrease ERα mRNA. At 165 
DPF, ERα mRNA was at the normal level.  
 
Fig. 11 Influence of EE2 exposure on IGF-I gene expression in male and female gonad. (A-D) Relative changes 
(log 2) of IGF-I (A,C) and  ERα (B,D) mRNA expression in EE2-treated as compared to age-matched control 
tilapia. (E-H) In situ hybridisation with IGF-I antisense probe. (E,F) Male gonad at 90 DPF. Arrows point to 
IGF-I mRNA-expressing spermatogonia. (G,H) Female gonad at 75 DPF. Fewer IGF-I mRNA signals are found 
in granulosa cells (black arrow heads) and in small oocytes (white arrows) of EE2-treated fish (H) than in 
controls (G). X-axis is labelled as DPF. Columns give mean values and bars SD. Significance level: * P=0.028, 
P=0.015, ** P=0.006, P=0.009, P=0.0013. 
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3.2.7. IGF-I mRNA and ERα mRNA levels in gills 
 
Significant changes in IGF-I mRNA expression were obtained only at 50 DPF in males  
where it was decreased by the 5.9-fold (P=0.02). No significant changes in IGF-I mRNA were 
detected in males lateron or in females at any experimental stage (Fig. 12A,C). Using in situ 
hybridisation, the number of IGF-I mRNA containing chloride cells in the gill filament 
epithelium was found to be reduced in EE2-treated males at 50 DPF (Fig. 12E,F). At 50 DPF, 
branchial ERα mRNA was significantly decreased in both sex, in males by the 27-fold 
(P=0.03) and in females by the 3.2-fold (P=0.03). At the later stages, no significant changes 
were obtained (Fig. 12B,D). 
 
 
 
Fig. 12 Influence of EE2 exposure on IGF-I and ERα mRNA in gill filaments. (A-D) Relative changes (log 2) of 
IGF-I (A,C) and ERα (B,D) mRNA expression in EE2-treated as compared to age-matched control tilapia. (E, F) 
In situ hybridisation with IGF-I antisense probe in gill specimens of 50 DPF male tilapia. Black arrows point to 
IGF-I mRNA containing chloride cells in the gill filament epithelium. X-axis is labelled as DPF. Columns give 
mean values and bars SD. Significance level: * P=0.03, P=0.02. 
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3.2.8. Pituitary GH mRNA levels 
 
Pituitaries could be dissected only at 75, 90 and 165 DPF. GH mRNA was significantly 
decreased after EE2 treatment in male pituitary at 165 DPF (P=0.0571) by the 2.33-fold (Fig. 
13A) and in female pituitary at 75 DPF by the 2.27-fold (P=0.0571) and at 90 DPF to the 3-
fold (P=0.0571) (Fig 13C). ERα mRNA was significantly (P=0.0061) raised to the 3.38-fold 
at 165 DPF in the male pituitary (Fig. 13B) and in the female pituitary to the 2.55-fold at 75 
DPF (P=0.0159) and at 90 DPF (P=0.0012) to the 2.7-fold (Fig. 13D). 
 
Fig. 13 Influence of EE2 exposure on GH and ERα mRNA levels in male (A,B) and female (C,D) tilapia 
pituitary revealed by real time PCR. Relative changes (log 2) of GH (A,C) and ERα (B,D) mRNA expression in 
EE2-treated as compared to age-matched control tilapia. X-axis is labelled as DPF. Columns give mean values 
and bars SD. Significance level: * P=0.0159, P=0.0571, ** P=0.0061, P=0.0012. 
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3.3. Environmental dose EE2 treatment 
 
Our experiments with feeding of high doses of 17a-ethinylestradiol (EE2) indicated that 
developmental estrogen treatment impairs GH/IGF-I expression in fish, and that these effects 
persist. Consecutively, we studied the effects of exposure to low doses of EE2 on early 
developing tilapia. 
 
3.3.1. Water concentration 
 
Measurements of the actual EE2 concentrations after 36 h of exposure revealed in controls 
0.088 ± 0.021 ng EE2/L, in the 5 ng EE2/L aquaria 4.34 ± 0.85 ng EE2/L, and in the 25 ng 
EE2/L aquaria 16.23 ± 5.74 ng EE2/L. Thus, the actual EE2 concentrations were below the 
applied ones. 
 
3.3.2. Sex ratio  
 
As obvious from Table 1, the female and male monosex fish populations after exposure to 
both 5 and 25 ng EE2/L exhibited a higher percentage of females at 75 and 100 DPF. 
  
Female monosex 75 DPF 100 DPF Male monosex 75 DPF 100 DPF 
 
Control 78.7% 77.4% Control 83.3% 81.7 % 
 
5 ng EE2/L 83.3% 97.5% 5 ng EE2/L 78.4% 72.2% 
 
25 ng EE2/L 91.6% 96.6% 25 ng EE2/L 75.0% 68.1% 
 
 
Table 1  Sex ratio (%) of tilapia monosex populations after exposure to 5 and 25 ng EE2/L determined at 75 and 
100 DPF. 
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3.3.3. Somatic indices 
 
Exposure to EE2 affected growth more pronouncedly in male than in female fish. In male 
fish, from 50 DPF on both body length and weight were significantly reduced in fish exposed 
either in 5 or in 25 ng EE2/L. At the end of the experiment (100 DPF), in males body length 
(Fig.14A) was reduced by about 9.5% (5 ng EE2/L) and 11% (25 ng EE2/L) and body weight 
(Fig.14C) by about 25% at both EE2 concentrations. In female fish, both parameters showed 
only a trend to decrease. Here at 100 DPF, body length (Fig.14D) was reduced by about 3% 
(5 ng EE2/L) and 6.2% (25 ng EE2/L) and body weight (Fig. 14F) by about 14% at 25 ng 
EE2/L concentrations. 
 
Fig. 14 Influence of EE2 exposure on fish growth throughout the experimental period. Body length (A,D, in cm) 
and weight (B,C,E,F, in g) in male (A,B,C) and female (D,E,F) tilapia.White columns: control, gray columns: 5 
ng EE2/L, black columns: 25 ng EE2/L. X-axis is labelled as DPF. Columns give mean values and bars SD. 
Significance levels: * P <0.01; ** P<0.005; *** P<0.0005. 
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3.3.4. Impact on liver IGF-I and ERα gene expression  
 
In both sexes, an initial (30 DPF) significant upregulation of IGF-I mRNA levels (Fig. 
15A,C), even at the lower EE2 concentration (5 ng EE2/L), was observed (male: 2.82-fold, 
P=0.0007; female: 2.43-fold, P=0.003) which was accompanied in both sexes by elevated 
ERα levels (Fig. 15B,D) at 5 ng EE2/L (male: 1.77-fold, P=0.007; female: 2.24-fold, 
P=0.0007) and in females (Fig. 15D) also at 25 ng EE2/L (2.66-fold, P=0.0007). In males, 
already about 6 weeks of exposure (50 DPF), IGF-I gene expression (Fig. 15A) was highly 
significantly reduced at 25 ng EE2/L (-2.38-fold, P=0.0003) followed by a highly significant 
suppression of IGF-I mRNA levels at both concentrations, 5 ng EE2/L (-2.94-fold, P=0.0006) 
and 25 ng EE2/L (-4.17-fold, P=0.0006) which persisted until end of treatment (100 DPF). 
IGF-I gene expression dynamics were rather paralleled by significant down-regulations of 
ERα gene expression levels (Fig. 15B) at 75 DPF (5 ng EE2/L: -1.64-fold, P=0.0047; 25 ng 
EE2/L: -2.7-fold, P=0.0003) and 100 DPF (-2.08-fold, P=0.0082). Similar dynamics like in 
males were observed in females whereby the suppressed IGF-I mRNA levels (Fig. 15C) 
occurred later than in males: 75DPF (-1.41-fold, P=0.0093) and 100 DPF(-1.85-fold, 
P=0.015). Also in the female fish, the observed IGF-I mRNA levels coincided with a, 
however less pronounced, suppression (-1.59-fold, P=0.05) of ERα mRNA (Fig. 15D). 
 
 
Fig. 15 Influence of EE2 exposure on IGF-I (A,C) and ERα (B,D) mRNA levels in tilapia male (A,B) and 
female (C,D) liver revealed by real time PCR. EE2-treated and age–matched control tilapia were used. X-axis is 
labelled as DPF. Columns give mean values and bars SD. White columns: 5 ng EE2/L, black columns: 25 ng 
EE2/L. Significance level: * P=0.015, P=0.02, P=0.05;** P=0.0012, P=0.003,P=0.0047, P=0.007, P=0.0082, 
P=0.0093; *** P=0.0003, P=0.0006, P=0.0007. 
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3.3.5. Impact on brain IGF-I and ERα gene expression 
 
Exposure of male brain to EE2 significantly induced ERα gene expression (Fig. 16B) at the 
earliest time point investigated (30 DPF), at both concentrations (5 ng EE2/L: 1.76-fold, 
P=0.0499; 25 ng EE2/L: 1.73-fold, P=0.0379). Nevertheless, only at the high concentration of 
25 ng EE2/L IGF-I mRNA levels (Fig. 16A) were significantly suppressed (-1.41-fold, 
P=0.0499), an effect that persisted until 50 DPF (-1.72-fold, P=0.0148) where ERα gene 
expression levels were still, but not significantly, elevated. Lateron, IGF-I gene was 
unaffected despite a significant down-regulation of ERα (-1.89-fold, P=0.0011) at the latest 
time-point investigated (100 DPF, Fig. 16B). In female brain, ERα gene levels (Fig. 16D) 
were suppressed over the whole treatment phase, but only rarely (5 ng EE2/L at 50 DPF: -
1.53. P=0.0152; and 25 ng EE2/L at 100 DPF: -1.41-fold, P=0.0496) significantly. IGF-I gene 
expression levels (Fig. 16C) revealed an initial upregulation at 30 DPF (25 ng EE2/L: 2.16-
fold, P=0.0012) followed by significant suppression at 50 DPF at both concentrations (5 ng 
EE2/L: -1.59-fold, P=0.0002; 25 ng EE2/L: -1.47-fold, P=0.0133). At 75 DPF, a recovery was 
observed at the higher concentration whereas at 5 ng EE2/L, a significant suppression (-2.38-
fold, P=0.0001) was still observed followed by a significant elevation at 100 DPF (1.66-fold, 
P=0.0281). 
 
Fig. 16 In male brain, the ratios of IGF-I (A) and ERα mRNA (B) between EE2-treated and control tilapia 
changed over the experimental period. In female brain, IGF-I mRNA (C) is significantly reduced at 50 and 75 
DPF and ERα mRNA (D) downregulated at 50 and 100 DPF. X-axis is labelled as DPF. Columns give mean 
values and bars SD. White columns: 5 ng EE2/L, black columns: 25 ng EE2/L. Significance level: * P=0.0133, 
P=0.0148, P=0.0152, P=0.0205, P=0.0281; P=0.0379, P=0.0496, P=0.0499; ** P=0.0011, P=0.0012; *** 
P=0.0001, P=0.0002. 
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3.3.6. Impact on gonad IGF-I and ERα gene expression 
 
A marked sex-specific difference was observed in the gonads: in males (Fig. 17B), ERα was 
continuously, in part significantly, suppressed: initially, at 30 DPF at 25 ng EE2/L (-2.09-fold, 
P=0.0339), and later, at 50 DPF (-2.73-fold,P=0.0286) and 100 DPF (-1.95-fold, P=0.0037), 
at the low EE2 concentration (Fig. 17B). The continuously suppressed ERα gene expression 
levels were paralleled by continuously, in part significantly, down-regulated IGF-I gene 
expression levels (Fig. 17A) at 50 DPF (5 ng EE2/L: -3.04-fold, P=0.0286; 25 ng EE2/L: -
6.07-fold, P=0.0286) and at 75 DPF (25 ng EE2/L: -2.33-fold, P=0.0303). Only at the latest 
time point investigated (100 DPF) when ERα was partly recovered (Fig. 17B) a significant 
upregulation of IGF-I mRNA (Fig. 17A) was observed at the higher EE2 concentration (25 ng 
EE2/L: 1.64-fold, P=0.0274). In females, no significant ERα gene expression change was 
detected (Fig. 17D). The IGF-I mRNA levels (Fig. 17C) were initially suppressed, but not 
significantly, and then showed a not significant but continuous elevation resulting in 
significantly elevated IGF-I mRNA levels at both EE2 water concentrations (5 ng EE2/L: 
3.17-fold, P=0.0023; 25 ng EE2/L: 2.55-fold, P=0.0082). 
 
Fig. 17 At 50 and 75 DPF, IGF-I mRNA in male (A) gonad of EE2-treated tilapia as revealed by real time PCR 
remains downregulated. At 100 DPF, in female (C) and in male (A) gonad the IGF-I mRNA level is significantly 
increased. ERα mRNA is significantly suppressed in the male gonads (B) at 30, 50 and 100 DPF. In the female 
gonad, ERα mRNA (D) remained unchanged through the whole experiment. X-axis is labelled as DPF. Columns 
give mean values and bars SD. White columns: 5 ng EE2/L, black columns: 25 ng EE2/L. Significance level:     
* P=0.0274, P=0.0286 , P=0.0303, P=0.0339; ** P=0.0023, P=0.0037 , P=0.0082. 
 
 55
3.3.7. Impact on gills IGF-I and ERα gene expression 
 
In male gills, alteration of the ERα gene levels (Fig. 18B) were only observed at the lower 
EE2 concentration (5 ng EE2/L) and these were significant upregulations at 30 DPF (1.73-
fold, P=0.0281) and 75 DPF (2.09-fold, P=0.0229). No IGF-I mRNA gene expression 
alteration (Fig. 18A) was observed at the lower EE2 concentration. But in contrast, at 25 ng 
EE2/L, a continuous suppression of IGF-I mRNA was detected starting at 30 DPF, at 50 DPF 
it was significant (-1.93-fold, P=0.0019), followed by a not significant upregulation at 100 
DPF (Fig. 18A). In female gills, ERα mRNA (Fig. 18D) was lowered, whereby the 
suppression at the higher EE2 concentration occurred earlier at 50 DPF (-2.33-fold, P=0.004) 
than at the lower concentration, started at 75 DPF (5 ng EE2/L: -1.75-fold, P=0.004; 25 ng 
EE2/L: -2.22-fold, P=0.0002) and persisted, but not significantly, until end of treatment. 
Whereas no alteration of IGF-I mRNA levels (Fig. 18C) occurred at the low EE2 
concentration, a significant down regulation was observed at 25 ng EE2/L at 50 DPF (-2.33-
fold, P=0.001) followed by a significant elevation at 75 DPF (1.72-fold, P=0.0111) and a 
recovery at 100 DPF. 
 
Fig. 18 Impact of EE2-treatment on IGF-I mRNA (A,C) and ERα mRNA (B,D) in gills. A significant decline in 
IGF-I mRNA expression was found only at 50 DPF in males (A) but no significant changes in IGF-I mRNA 
were detected in males lateron. In females at 50 DPF IGF-I mRNA (C) was downregulated with lateron 
compensatory recovery. In females, branchial ERα mRNA (D) was significantly decreased at 50 and 75 DPF. 
But in males, significant upregulations at 30 and 75 DPF were observed (B).  X-axis is labelled as DPF. 
Columns give mean values and bars SD. White columns: 5 ng EE2/L, black columns: 25 ng EE2/L. Significance 
level: * P=0.011, P=0.0229, P=0.0281; ** P=0.001, P=0.0019, P=0.004, P=0.002; *** P=0.0002. 
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4. Discussion 
 
Nothing is known about the potential interference of estrogen(s) and IGF-I during fish 
development. In our first experimental approach, we have used EE2-feeding from 10 to 40 
DPF, a period that includes the sensitive period of gonad differentiation. The effects of this 
treatment have been determined at 50, 75, 90 (puberty) and 165 (adult) DPF and will be first 
discussed. 
EE2 feeding led to a lasting decline in growth that was most pronounced at the end of 
the experiment (165 DPF) i. e. about three months after end of the treatment, in the young 
adult individuals. Then, body weight was reduced compared to controls in males by about 
46% and body length by 19.5%, and in females by about 40% and 15%, respectively. Thus, 
EE2-feeding for about one month during the sensitive phase of sexual development resulted in 
severe and persistent growth impairment in both sex.  
Although growth reducing effects of continuous estrogen exposure on developing fish 
have been shown in some studies, less information is available whether estrogen exposure 
during specific developmental stages leads to altered growth later in life. Treatment of 
embryonic trout with estrogen-receptor-binding alkylphenols until 21 DPF resulted in a 
permanently suppressed growth until 400 DPF (Ashfield et al., 1998). This finding agrees 
with our observation that developmental estrogen exposure evoked a persistent reduction of 
tilapia growth. The question is if this permanent growth-suppressing effect is caused by an 
interaction with the GH/IGF-I system, be it directly and/or indirectly. To this end, we 
analysed parameters of the GH/IGF-I system, in a series of target and effector organs, such as 
liver, gonads, brain, pituitary and gills, and both at the transcriptional and translational level.  
Feeding of tilapia with EE2 during early development resulted in a significant 
decrease in circulating serum IGF-I by about 30% at 75 DPF, i.e. about one month after end 
of treatment. This decline was highly significant in males, and in females showed a clear 
tendency. In agreement, the somatic indices were more pronouncedly lowered in males than 
in females. The decreased serum IGF-I was in parallel with a high and significant decrease in 
IGF-I mRNA in liver of both sexes, the main source of endocrine IGF-I, and a reduced 
number of IGF-I mRNA expressing hepatocytes as shown by in situ hybridisation. Further, 
the decline in hepatic IGF-I synthesis was accompanied by a significant induction of ERα 
mRNA which was most pronounced at the time of the strongest decline of hepatic IGF-I 
expression. ERα mRNA was induced by EE2 treatment also in other tissues such as pituitary 
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or brain, and this response represents the well-characterised autoregulatory effect of estrogens 
on their own receptors, as it has been shown also for other fish species, e.g., (Filby et al., 
2007). However, it needs to be emphasised that the association between the upregulation of 
ERα and the altered expression of IGF-I, as observed in our study, does not implicate a 
mechanistic link between the two observations. However, even without assuming a causative 
role of the EE2-induced activation and upregulation of the ER pathway, our results suggest 
that administration of EE2 during early development exerts a long-term suppressive effect on 
hepatic IGF-I expression and synthesis. Previous in vivo and in vitro studies in adults of 
different fish species also reported an estrogen-associated decrease in hepatic IGF-I mRNA 
(Riley et al., 2004; Carnevali et al., 2005; Filby et al., 2006) or in serum IGF-I (Arsenault et 
al., 2004; McCormick et al., 2005). 
However, effects obtained in the other studies occurred during ongoing estrogen 
treatment while the effects observed in our study represent lasting effects of exposure earlier 
in life. The EE2 effect on IGF-I of tilapia was partly gender-specific. For instance, the EE2-
induced decrease in liver IGF-I mRNA appeared earlier (50 DPF) in males than in females 
(75 DPF). Interestingly, this was paralled by a later increase in ERα mRNA expression in 
females, suggesting a causative link between these events, although we cannot prove this on 
the basis of our data. Sex-specific responses of the IGF-I system of fish to estrogens have 
been reported also by Filby et al. (2006), who found that the hepatic expression of IGF-I in 
adult fathead minnow exhibited a high and significant decrease in males exposed to E2 but 
only an insignificant one in females. Gender differences in the response of IGF-I to estrogens 
may indicate that the estrogen effects on IGF-I expression in organs such as the liver do not 
not only result from a direct, local crosstalk between the two hormone systems, but 
interactions at the hypothalamus-pituitary level and subsequent systemic changes may be 
involved as well. Interestingly, brain IGF-I mRNA was responsive to developmental EE2 
treatment only in female tilapia. Here the suppression of IGF-I expression obtained by real-
time PCR was paralled by an overall decrease in IGF-I mRNA signals in neurons as found by 
in situ hybridisation.  
Furthermore, fish of either sex fed with EE2 exhibited a significant decrease in GH 
mRNA which was accompanied by a significant upregulation of the ERα. Evidence for effects 
of estrogens on the fish pituitary GH gene is conflicting. While in some studies no effects of 
E2 on GH mRNA were revealed (Melamed et al., 1998; Filby et al., 2006), others report that 
E2 stimulated GH synthesis and secretion, but not gene transcription (Holloway and 
Leatherland, 1997; Zou et al., 1997). The discrepancy between these studies and the present 
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one may be due to the different estrogens used, to different modes of application or to 
hormone application at different life stages or physiological states of the fish. The reduction in 
pituitary GH mRNA as observed here may well be caused by a direct effect of EE2 on the 
pituitary GH cells. However, EE2 may have also suppressed GH release at the hypothalamic 
level because E2 increased the expression of somatostatin-14 in goldfish brain (Canosa et al., 
2002). 
In the gonads, IGF-I occurs during the juvenile and adult stage in testes in 
spermatogonia, spermatocytes, Sertoli and Leydig cells (Le Gac et al., 1996; Reinecke et al., 
1997; Berishvili et al., 2006b) and in the ovary in small and previtellogenic oocytes and in 
follicular granulosa and theca cells (Schmid et al., 1999; Perrot et al., 2000; Berishvili et al., 
2006b). In Japanese eel cultured testes, IGF-I stimulated spermatogenesis induced by 11-
ketosterone (Nader et al., 1999). In rainbow trout, testicular IGF-I increased after GH-
treatment (Le Gac et al., 1996; Biga et al., 2004) and both GH and IGF-I stimulated the 
incorporation of thymidine into spermatogonia and primary spermatocytes (Loir, 1999). In the 
ovary of different fish species, IGF-I stimulated thymidine incorporation in vitellogenic 
follicles (Srivastava and Van  der  Kraak, 1994), promoted oocyte maturation (Kagawa et al., 
1994; Negatu et al., 1998) and selectively influenced the production of sex steroids in theca 
and granulosa cells (Maestro et al., 1997). Hence, IGF-I most likely acts as 
paracrine/autocrine regulator of fish spermatogenesis and oocyte proliferation and maturation 
in interaction with steroid hormones.  
Feeding with EE2 caused a significant reduction in IGF-I mRNA in both ovaries and 
testes. The downregulation occurred earlier in female than in male gonad. In agreement with 
the PCR results, in situ hybridisation showed in testes a decrease in the number of IGF-I 
mRNA containing spermatogonia, and in ovary a reduction of IGF-I expression in small 
oocytes and granulosa cells after EE2 treatment.  
Remarkably, the ERα mRNA showed a long-term induction by EE2 feeding only in 
the testes while in the female gonad a significant downregulation of the ERα mRNA was 
obtained at 75 DPF after an initial upregulation at 50 DPF. Similarly, in adult fathead minnow 
exposed to E2 for 14 days, Erα mRNA was also increased in male and decreased in female 
gonad (Filby et al., 2006). Thus, ER signaling pathway and IGF-I expression of male and 
female gonads show differential responses to EE2 exposure what might indicate that in this 
case the EE2 effects on IGF-I are not mediated through the ER pathway. 
Overall, from the present results, two options for explaining the impairing effects of 
estrogens on growth, differentiation and function of fish gonads are likely: They may be 
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exerted via suppression of IGF-I production in liver resulting in a lowered level of circulating 
(endocrine) IGF-I and/or by the reduction of autocrine/paracrine IGF-I expression within the 
gonads as discussed above. 
In gill filaments, only males exhibited a significant decrease in IGF-I mRNA at 50 
DPF that is reflected at the cellular level by a reduction of the number of IGF-I mRNA 
containing chloride cells, while no significant changes were present throughout the 
experimental period in females. The results at 50 DPF, i.e. 10 days after end of the treatment, 
agree in part with those obtained in the adult cyprinid fathead minnow exposed to E2 for 14 
days (Filby et al., 2006): IGF-I mRNA was amplified only in the gills of some fish and, here a 
down-regulation was found in both sexes. IGF-I seems to have a physiological impact on 
smoltification. The chloride cells of the filament epithelium not only express Na+,K+-ATPase 
(McCormick, 1996) but in developing and adult fish also IGF-I mRNA (Reinecke et al., 1997; 
Radaelli et al., 2003; Berishvili et al, 2006a). In tilapia, the importance of local IGF-I 
expression is stressed by its very early appearance in chloride cells around 6-7 DPF 
(Berishvili et al. 2006a). In several fish species, evidence has been presented that both 
circulating (liver-derived) IGF-I (Madsen and Bern, 1993; Shepherd et al., 1997; Inoue et al., 
2003) and autocrine/paracrine IGF-I from the chloride cells (Sakamoto and Hirano, 1993; 
Biga et al., 2004) mediate the osmoregulatory actions of GH. Previous studies have reported 
that E2 impairs osmoregulation in salmonid (Arsenault et al., 2004; Madsen et al., 2004; 
McCormick et al., 2005) and non-salmonid (Vijayan et al., 2001) fish, and suppressed plasma 
levels of IGF-I were thought to be the underlying mechanism (McCormick et al., 2005). The 
present results not only support this idea but also suggest a direct effect of estrogens on IGF-I 
production in gill filaments in addition to the endocrine route. This is not only indicated by the 
present PCR results but also by the observed decrease of IGF-I mRNA in chloride cells as 
revealed by in situ hybridisation. 
The findings from our EE2 feeding experiments on developing fish are in line with 
some earlier findings on adult fish that estrogen(s) are able to modulate IGF-I transcription 
and translation in liver (Riley et al., 2004; Carnevali et al., 2005; Filby et al., 2006) or 
decrease serum IGF-I (Arsenault et al., 2004; McCormick et al., 2005).  
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In addition, the study provides evidence that estrogens applied during early 
development 
a) change the IGF-I system in liver and, concomitantly, circulating IGF-I and, thus, 
influence the endocrine route of IGF-I action,  
b) impair local IGF-I in other organs by changing IGF-I expression within the organ-
specific cells as shown by in situ hybridisation, and  
c) that the IGF-I response is associated with a change of pituitary GH expression.  
Thus, the estrogen effect on IGF-I seems to involve both direct (autocrine/paracrine) 
interactions in peripheral organs as well as indirect (endocrine) effects via modulation of the 
brain-pituitary GH system. Our results also for the first time provide evidence that 
developmental estrogen exposure can have long-lasting effects on the GH/IGF-I system.  
As first and successful approach we used a dietary EE2 concentration in the range 
used for intended feminisation of tilapia in aquaculture (Piferrer 2001) to reveal whether 
interactions between the estrogen and the GH/IGF-I system in principal can take place. 
Dietary application of estrogens, similar to injection of estrogens that has also often been 
described, therefore represents an articifical exposure situation which is useful to provide 
principal information on mechanisms and targets but not to assess the environmental hazard 
of estrogens. Thus, in a second set of experiments we have investigated whether 
environmentally relevant concentrations of EE2, i.e. 5 and 25 ng EE2/L surrounding water, 
also affect the fish IGF-I system.  
To this end, we have incubated both a male and a female monosex populations from 10 
to 100 DPF at the concentrations 5 ng/L EE2 and 25 ng/L EE2 and determined the effects of 
EE2 exposure at 30, 50, 75 and 100 DPF.  
In our study we have exposed developing tilapia with low concentrations of EE2 in the 
surrounding water. In numerous countries, remarkable concentrations of EE2 have been 
determined in the environment. In Germany, concentrations of EE2 in rivers ranged between 1 
ng/L (Hintemann et al., 2006) and 5 ng/L (Kuch and Ballschmiter 2001) while in WWTP 
effluents they were 3 ng/L (Hintemann et al., 2006), 9 ng/L (Kuch and Ballschmiter, 2001) and 
15 ng/L (Ternes et al., 1999). Similarly, EE2 concentrations in effluents in the UK were around 
7 ng/L (Desbrow et al., 1998), in the Acushnet River Estuary in the USA 4.7 ng/L (Zuo et al., 
2006), in a river in Taipei up to 15 ng/l (Chen et al., 2007). In France and the Netherlands 3-4 
ng EE2/L were detected in coastal water and rivers and 4-8 ng EE2/L in effluents (Belfroid et 
al., 1999; Cargouet et al., 2004). In a Canadian study even up to 42 ng EE2/L were reported in 
effluents (Ternes et al., 1999). Thus, the actual exposure concentrations of EE2, i.e. on average 
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4.34 ng EE2/L and 16.23 ng EE2/L, used in our study, are well within the range determined for 
EE2 in the environment.  
Sex ratio had shifted at 75 and 100 DPF. Both the female and male monosex fish 
populations exhibited a higher percentage of females after exposure to both 5 and 25 ng EE2/L. 
Thus, as the high EE2 doses applied in our feeding experiment, environmentally relevant 
concentrations of EE2 also led to feminisation while no hermaphrodites were found. In further 
parallel to the effects of EE2 feeding growth and length of the exposed fish were also 
decreased. The results of our exposure experiments support those obtained in zebra fish that 
was also exposed to environmentally relevant concentrations of EE2 (up to 10 ng EE2/L) and 
also showed  impaired juvenile growth (Schafers et al., 2007). 
In both sex, after an initial significant upregulation of the IGF-I mRNA levels at both 
EE2 concentrations (5 and 25 ng EE2/L) the expression of IGF-I mRNA in liver was reduced. 
This is in agreement with previous studies where adults of different fish species were exposed 
to E2 resulting also in an estrogen-associated decrease in hepatic IGF-I mRNA (Riley et al., 
2004; Carnevali et al., 2005; Filby et al., 2006). The suppression of liver IGF-I mRNA in both 
sexes was accompanied by a downregulation of the ERα. The latter result is in contrast to 
those obtained by our EE2 feeding experiments and those described in adult fathead minnow 
(Filby et al., 2006) where the decrease in IGF-I mRNA was accompanied by an upregulatuion 
of the ERα. It is conceivable that the long-term exposure to EE2 in our experiments - that first 
led to an upregulation of the ERα as expected - may have caused the downregulation possibly 
indicating some over-compensation. 
Under exposure to low concentrations of EE2, the expressions of the genes 
investigated showed some sex-specificity in the gonads. In males, ERα was continuously 
downregulated while in females no significant alterations occurred. IGF-I mRNA in testes 
was transiently decreased but in females after an initial trend to decrease IGF-I mRNA was 
upregulated at 100 DPF. Recent evidence obtained in zebra fish exposed to low 
concentrations of EE2 (up to 10 ng EE2/L) in surrounding water indicated not only a 
reduction of juvenile growth but also an impairment of sexual maturity, adult fecundity and 
fertilisation success (Schafers et al., 2007). Based on the present results it is assumed that the 
observed impairing effects of EE2 on reproductive processes may be due to a downregulated 
expression of IGF-I mRNA in the gonads, particularly in testes. Furthermore, it is likely that 
the feminisation found in the present study is a further parameter that impairs fertilisation 
success. 
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Individual growth has consequences for demographic parameters such as age-specific 
survival, time to maturation or fecundity. Thus, our findings obtained by both experimental 
approaches point to a potentially important mechanism through which environmental 
estrogens, in addition to their direct effect on fish reproduction, could alter population growth 
of fish species.  
Future research has to address the mechanism(s) through which estrogen(s) act to 
suppress pituitary GH and local IGF-I expression in liver and extrahepatic sites. In particular, 
given our findings on the correlation between ER and IGF-I changes, it would be important to 
examine whether the EE2 effects on the GH/IGF-I system are mediated through the ER 
pathway and/or through other mechanisms. 
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